Back to results

Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) (ALTITUDE)

Primary Purpose

Type 2 Diabetes Mellitus, Cardiovascular Disease

Status

Terminated

Phase

Phase 3

Locations

International

Study Type

Interventional

Intervention

Aliskiren

Placebo

About this trial

This is an interventional treatment trial for Type 2 Diabetes Mellitus focused on measuring Type 2 diabetes mellitus, renal morbidity and mortality, cardiovascular disease, micro-albuminuria, macro-albuminuria, RAAS, renin inhibitor, Reduced estimated glomerular filtration rate

Eligibility Criteria

35 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Type 2 diabetes and at least one of the following:
- Macroalbuminuria and an eGFR ≥30 mL/min/1.73 m2
- Microalbuminuria and a reduced kidney function (eGFR eGFR ≥30 and <60 mL/min/1.73 m2)
- A history of CV disease (previous MI, previous stroke, heart failure, coronary artery disease, history of percutaneous coronary intervention, angiography proven stenosis ≥50% in at least one coronary artery and a reduced kidney function (eGFR ≥30 and <60 mL/min/1.73 m2)
Concomitant treatment should follow national guidelines and must include either an Angiotensin-converting-enzyme-inhibitor (ACEi) or an Angiotensin-receptor-blocker (ARB) but not both.

Exclusion Criteria:

Type 1 diabetes mellitus
Cardiovascular event or procedure ≤ 3 months prior to Visit 1
Unstable serum creatinine
Hypertension: Mean sitting systolic blood pressure (msSBP) ≥ 135 and < 170 mmHg or Mean sitting diastolic blood pressure (msDBP) ≥ 85 and < 110 mmHg unless treated with at least 3 anti-hypertensive medications
Hypertension msSBP ≥ 170 or msDBP ≥ 110 mmHg
Baseline Serum Potassium > 5.0 mmol/L
Patients who are treated with two renin-angiotensin-aldosterone-system-blockers
Patients with NYHA class III or IV heart failure
Known renal artery stenosis
Previous randomization into the AVOID trial (CSPP100C2201)

EXCLUSION SPECIFIC TO THE SAFETY FOLLOW-UP PERIOD:

- Aliskiren or aliskiren containing fixed combination products must not be used

Other protocol-defined inclusion/exclusion criteria applied

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Aliskiren

Placebo

Arm Description

In Core (Double Blind) phase, Aliskiren 150 mg once daily (o.d.) for 4 weeks; then patient was uptitrated to 300 mg o.d. at Visit 5/Week 4 (or 150 mg o.d. if patient could not tolerate target dose of study drug). Visits took place at 1, 4 , 5, 8 and 12 weeks after randomization (Visit 3/Week 0). Subsequent visits were planned every three months until end of core phase. With the recommendation of Data Monitoring Committee (DMC), after discontinuation of study drug, a follow up was added as Extension Phase (9 months in average) with no active treatment

In Core (Double Blind) phase, placebo to match aliskiren 150 mg once daily (o.d.) for 4 weeks; from Visit 5/Week 4 placebo to match aliskiren 300 mg o.d. (or placebo to match aliskiren 150 mg if patient could not tolerate target dose of study drug). Visits took place 1, 4 , 5, 8 and 12 weeks after randomization (Visit 3/Week 0). Subsequent visits were planned every three months until end of core phase. With the recommendation of Data Monitoring Committee (DMC), after discontinuation of study drug, a follow up was added as Extension Phase (9 months in average) with no active treatment.

Outcomes

Primary Outcome Measures

Percentage of Participants With Occurrence of Primary Composite Endpoint (Core : Active Treatment Phase)

Occurrence was defined as the first event of the following composite primary endpoint: Cardiovascular (CV) death Resuscitated sudden death Non-fatal myocardial infarction (MI) Non-fatal stroke Unplanned hospitalization for heart failure (HF) Onset of end-stage renal disease (ESRD) or death due to renal failure. Onset of ESRD was defined as initiation of dialysis, renal transplantation, or a serum creatinine concentration above 6.0 mg/dL (530 μmol/L), sustained for at least a month. Doubling of baseline serum creatinine concentration, sustained for at least one month. To fulfill the endpoint, the serum creatinine concentration had to be above the upper limit of normal for men and women according to the central laboratory. The upper limit of normal for men is 1.20 mg/dL and for women is 0.91 mg/dL.

Percentage of Participants With Cardiovascular (CV) Death (Core: Active Treatment Phase)

Percentage of Participants With Resuscitated Sudden Death (Core: Active Treatment Phase)

Resuscitated sudden death was adjudicated when a subject experiences sudden death or cardiac arrest and is successfully resuscitated by cardioversion, defibrillation or cardiopulmonary resuscitation with a meaningful recovery of consciousness. This definition excludes known transient losses of consciousness such as seizure or vasovagal episodes that do not reflect significant cardiac dysfunction.

Percentage of Participants With Fatal/Non-fatal Myocardial Infarction (MI) (Core: Active Treatment Phase)

Percentage of Participants With Fatal/Non-fatal Stroke (Core: Active Treatment Phase)

Percentage of Participants With Onset of End-stage Renal Disease (ESRD) (Core: Active Treatment Phase)

ESRD is defined as initiation of dialysis, renal transplantation, or a serum creatinine concentration above 6.0 mg/dL (530 µmol per liter) or renal death

Percentage of Participants With Doubling of Baseline Serum Creatinine Concentration, Sustained for at Least One Month (Core: Active Treatment Phase)

To fulfill the endpoint, the serum creatinine concentration had to be above the upper limit of normal for men and women according to the central laboratory. The upper limit of normal for men is 1.20 mg/dL and for women is 0.91 mg/dL.

Percentage of Participants With Unplanned Hospitalization for Heart Failure (Core: Active Treatment Phase)

Percentage of Participants With All Cause Mortality (Core: Active Treatment Phase)

Percentage of Participants With Occurrence of Primary Composite Endpoint (Extension Phase)

Percentage of Participants With Cardiovascular (CV) Death (Extension Phase)

Percentage of Participants With Resuscitated Sudden Death (Extension Phase)

Percentage of Participants Fatal/Non-fatal Myocardial Infarction (MI) (Extension Phase)

Percentage of Participants With Fatal/Non-fatal Stroke (Extension Phase)

Percentage of Participants With Onset of End-stage Renal Disease (ESRD) (Extension Phase)

ESRD is defined as initiation of dialysis, renal transplantation, or a serum creatinine concentration above 6.0 mg/dL (530 µmol per liter) or renal death

Percentage of Participants Doubling of Baseline Serum Creatinine Concentration, Sustained for at Least One Month (Extension Phase)

Percentage of Participants With Unplanned Hospitalization for Heart Failure (Extension Phase)

Percentage of Participants With All Cause Mortality (Extension Phase)

Secondary Outcome Measures

Percentage of Participants With Occurrence of Secondary Cardiovascular Composite Endpoint (Core: Active Treatment Phase)

Occurrence was defined as the first event of the following secondary cardiovascular composite endpoint: Cardiovascular (CV) death Resuscitated sudden death Non-fatal myocardial infarction (MI) Non-fatal stroke Unplanned hospitalization for heart failure (HF)

Percentage of Participants With Occurrence of Secondary Renal Composite Endpoint (Core: Active Treatment Phase)

Occurrence was defined as the first event of the following secondary renal composite endpoint: Onset of end-stage renal disease (ESRD) or death due to renal failure. Onset of ESRD was defined as initiation of dialysis, renal transplantation, or a serum creatinine concentration above 6.0 mg/dL (530 μmol/L), sustained for at least a month. Doubling of baseline serum creatinine concentration, sustained for at least one month. To fulfill the endpoint, the serum creatinine concentration had to be above the upper limit of normal for men and women according to the central laboratory.The upper limit of normal for men is 1.20 mg/dL and for women is 0.91 mg/dL.

Percentage of Participants With Occurrence of Secondary Cardiovascular Composite Endpoint (Extension Phase)

Percentage of Participants With Occurrence of Secondary Renal Composite Endpoint (Extension Phase)

Occurrence was defined as the first event of the following secondary renal composite endpoint: Onset of end-stage renal disease (ESRD) or death due to renal failure. Onset of ESRD was defined as initiation of dialysis, renal transplantation, or a serum creatinine concentration above 6.0 mg/dL (530 μmol/L), sustained for at least a month. Doubling of baseline serum creatinine concentration, sustained for at least one month. To fulfill the endpoint, the serum creatinine concentration had to be above the upper limit of normal for men and women according to the central laboratory. The upper limit of normal for men is 1.20 mg/dL and for women is 0.91 mg/dL.

Full Information

NCT ID

NCT00549757

First Posted

October 24, 2007

Last Updated

April 1, 2014

Sponsor

Novartis Pharmaceuticals

1. Study Identification

Unique Protocol Identification Number

NCT00549757

Brief Title

Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)

Acronym

ALTITUDE

Official Title

A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Determine Whether, in Patients With Type 2 Diabetes at High Risk for Cardiovascular and Renal Events, Aliskiren, on Top of Conventional Treatment, Reduces Cardiovascular and Renal Morbidity and Mortality

Study Type

Interventional

2. Study Status

Record Verification Date

April 2014

Overall Recruitment Status

Terminated

Why Stopped

Lack of benefit and safety concern

Study Start Date

October 2007 (undefined)

Primary Completion Date

February 2013 (Actual)

Study Completion Date

February 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title

Sponsor

Name of the Sponsor

Novartis Pharmaceuticals

4. Oversight

5. Study Description

Brief Summary

The purpose of this study was to determine whether, in patients with type 2 diabetes and pre-existing disease of the heart and the circulatory system and/or the kidney, aliskiren at a target dose of 300 mg once daily (compared to placebo), on top of conventional treatment, reduces death and disease caused by the heart, the circulatory system and the kidney. AMENDMENT 4 RATIONALE (MARCH 2012) : Protocol amendment 4 served to address the data monitoring committee recommendation dated 14 Dec 2011 to discontinue study treatment in all participating patients. It also addressed the subsequent Health Authorities request to implement a 12 month safety follow-up period (actual duration was 9 months in average) post study drug discontinuation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Type 2 Diabetes Mellitus, Cardiovascular Disease

Keywords

Type 2 diabetes mellitus, renal morbidity and mortality, cardiovascular disease, micro-albuminuria, macro-albuminuria, RAAS, renin inhibitor, Reduced estimated glomerular filtration rate

7. Study Design

Primary Purpose

Treatment

Study Phase

Phase 3

Interventional Study Model

Parallel Assignment

Masking

ParticipantInvestigator

Allocation

Randomized

Enrollment

8606 (Actual)

8. Arms, Groups, and Interventions

Arm Title

Aliskiren

Arm Type

Experimental

Arm Description

Arm Title

Placebo

Arm Type

Placebo Comparator

Arm Description

Intervention Type

Drug

Intervention Name(s)

Aliskiren

Intervention Description

Aliskiren 150 mg film-coated tablets

Intervention Type

Drug

Intervention Name(s)

Placebo

Intervention Description

Placebo to match aliskiren 150 mg film-coated tablets

Primary Outcome Measure Information:

Title

Percentage of Participants With Occurrence of Primary Composite Endpoint (Core : Active Treatment Phase)

Description

Time Frame

Time from randomization to the first event (Maximum 50 months)

Title

Percentage of Participants With Cardiovascular (CV) Death (Core: Active Treatment Phase)

Time Frame

Time from randomization to the first event (Maximum 50 months)

Title

Percentage of Participants With Resuscitated Sudden Death (Core: Active Treatment Phase)

Description

Time Frame

Time from randomization to the first event (Maximum 50 Months)

Title

Percentage of Participants With Fatal/Non-fatal Myocardial Infarction (MI) (Core: Active Treatment Phase)

Time Frame

Time from randomization to the first event (Maximum 50 Months)

Title

Percentage of Participants With Fatal/Non-fatal Stroke (Core: Active Treatment Phase)

Time Frame

Time from randomization to the first event (Maximum 50 Months)

Title

Percentage of Participants With Onset of End-stage Renal Disease (ESRD) (Core: Active Treatment Phase)

Description

ESRD is defined as initiation of dialysis, renal transplantation, or a serum creatinine concentration above 6.0 mg/dL (530 µmol per liter) or renal death

Time Frame

Time from randomization to the first event (Maximum 50 Months)

Title

Percentage of Participants With Doubling of Baseline Serum Creatinine Concentration, Sustained for at Least One Month (Core: Active Treatment Phase)

Description

Time Frame

Time from randomization to the first event (Maximum 50 Months)

Title

Percentage of Participants With Unplanned Hospitalization for Heart Failure (Core: Active Treatment Phase)

Time Frame

Time from randomization to the first event (Maximum 50 Months)

Title

Percentage of Participants With All Cause Mortality (Core: Active Treatment Phase)

Time Frame

Time from randomization to the first event (Maximum 50 months)

Title

Percentage of Participants With Occurrence of Primary Composite Endpoint (Extension Phase)

Description

Time Frame

From cut-off date (20Dec2011/End of Treatment (EOT) ) to the first event after cut-off date (9 months in average)

Title

Percentage of Participants With Cardiovascular (CV) Death (Extension Phase)

Time Frame

from cut-off date (20Dec2011/End of Treatment (EOT) ) to the first event after cut-off date (9 months in average)

Title

Percentage of Participants With Resuscitated Sudden Death (Extension Phase)

Time Frame

From cut-off date (20Dec2011/End of Treatment (EOT) ) to the first event after cut-off date (9 months in average)

Title

Percentage of Participants Fatal/Non-fatal Myocardial Infarction (MI) (Extension Phase)

Time Frame

From cut-off date (20Dec2011/End of Treatment (EOT) ) to the first event after cut-off date (9 month in average)

Title

Percentage of Participants With Fatal/Non-fatal Stroke (Extension Phase)

Time Frame

From cut-off date (20Dec2011/End of Treatment (EOT) ) to the first event after cut-off date (9 months in average)

Title

Percentage of Participants With Onset of End-stage Renal Disease (ESRD) (Extension Phase)

Description

ESRD is defined as initiation of dialysis, renal transplantation, or a serum creatinine concentration above 6.0 mg/dL (530 µmol per liter) or renal death

Time Frame

From cut-off date (20Dec2011/End of Treatment (EOT) ) to the first event after cut-off date (9 months in average)

Title

Percentage of Participants Doubling of Baseline Serum Creatinine Concentration, Sustained for at Least One Month (Extension Phase)

Description

Time Frame

From cut-off date (20Dec2011/End of Treatment (EOT) ) to the first event after cut-off date (9 months in average)

Title

Percentage of Participants With Unplanned Hospitalization for Heart Failure (Extension Phase)

Time Frame

From cut-off date (20Dec2011/End of Treatment (EOT) ) to the first event after cut-off date (9 months in average)

Title

Percentage of Participants With All Cause Mortality (Extension Phase)

Time Frame

from cut-off date (20Dec2011/End of Treatment (EOT) ) to the first event after cut-off date (9 months in average)

Secondary Outcome Measure Information:

Title

Percentage of Participants With Occurrence of Secondary Cardiovascular Composite Endpoint (Core: Active Treatment Phase)

Description

Time Frame

Time from randomization to the first event (Maximum 50 months)

Title

Percentage of Participants With Occurrence of Secondary Renal Composite Endpoint (Core: Active Treatment Phase)

Description

Time Frame

Time from randomization to the first event (Maximum 50 months)

Title

Percentage of Participants With Occurrence of Secondary Cardiovascular Composite Endpoint (Extension Phase)

Description

Time Frame

From cut-off date (20Dec2011/End of Treatment (EOT) ) to the first event after cut-off date (9 months in average)

Title

Percentage of Participants With Occurrence of Secondary Renal Composite Endpoint (Extension Phase)

Description

Occurrence was defined as the first event of the following secondary renal composite endpoint: Onset of end-stage renal disease (ESRD) or death due to renal failure. Onset of ESRD was defined as initiation of dialysis, renal transplantation, or a serum creatinine concentration above 6.0 mg/dL (530 μmol/L), sustained for at least a month. Doubling of baseline serum creatinine concentration, sustained for at least one month. To fulfill the endpoint, the serum creatinine concentration had to be above the upper limit of normal for men and women according to the central laboratory. The upper limit of normal for men is 1.20 mg/dL and for women is 0.91 mg/dL.

Time Frame

From cut-off date (20Dec2011/End of Treatment (EOT) ) to the first event after cut-off date (9 months in average)

Other Pre-specified Outcome Measures:

Title

Percentage of Participants With Angioedema/Angioedema-like or Colorectal Events (Core : Active Treatment Phase)

Description

AEs of special interest were reported according to a post-marketing commitment to Health Authorities and included angioedema/angioedema-like events and colorectal events/ procedures

Time Frame

Time from randomization to the first event (Maximum 50 months)

Title

Change From Baseline in Urinary Albumin to Creatinine Ratio (UACR) to Month 6 and to Last Measurement (Core : Active Treatment Phase)

Description

Baseline is the geometric mean of last 3 measurements before visit 3, Post-baseline value is the geometric mean of last 3 measurements during each visit. Change from Baseline = Post - Baseline.

Time Frame

Baseline, Month 6 , last measurement (maximum at 50 months)

Title

Mean Changes in Estimated Glomerular Filtration Rate (eGFR) From Baseline to Month 3 and Month 6 (Core : Active Treatment Phase)

Description

The eGFR calculation was based on the Abbreviated Modification of Diet in Renal Disease (MDRD) Study Equation. Using this method, the applicable MDRD formula to calculate eGFR was as follows: Estimated GFR (mL/min/1.73 m^2) = 175 x (serum creatinine in mg/dL) -1.154 x (Age in years) -0.203 x (0.742 if female) x (1.210 if Black) Mean changes in eGFR from baseline to month 3 and month 6 were included for analysis. The LS Mean and Standard Error were based on an ANCOVA repeated-measure model with treatment, visit, treatment-by-visit and baseline eGFR as effect terms.

Time Frame

Baseline to Month 3 and Month 6

Title

Percentage of Participants With Angioedema/Angioedema-like Events or Colorectal Events (Extension Phase)

Description

AEs of special interest were reported according to a post-marketing commitment to Health Authorities and included angioedema/angioedema-like events and colorectal events/ procedures.

Time Frame

From cut-off date (20Dec2011/End of Treatment (EOT) ) to the first event after cut-off date (9 months in average)

10. Eligibility

Sex

All

Minimum Age & Unit of Time

35 Years

Accepts Healthy Volunteers

Eligibility Criteria

Inclusion Criteria: Type 2 diabetes and at least one of the following: Macroalbuminuria and an eGFR ≥30 mL/min/1.73 m2 Microalbuminuria and a reduced kidney function (eGFR eGFR ≥30 and <60 mL/min/1.73 m2) A history of CV disease (previous MI, previous stroke, heart failure, coronary artery disease, history of percutaneous coronary intervention, angiography proven stenosis ≥50% in at least one coronary artery and a reduced kidney function (eGFR ≥30 and <60 mL/min/1.73 m2) Concomitant treatment should follow national guidelines and must include either an Angiotensin-converting-enzyme-inhibitor (ACEi) or an Angiotensin-receptor-blocker (ARB) but not both. Exclusion Criteria: Type 1 diabetes mellitus Cardiovascular event or procedure ≤ 3 months prior to Visit 1 Unstable serum creatinine Hypertension: Mean sitting systolic blood pressure (msSBP) ≥ 135 and < 170 mmHg or Mean sitting diastolic blood pressure (msDBP) ≥ 85 and < 110 mmHg unless treated with at least 3 anti-hypertensive medications Hypertension msSBP ≥ 170 or msDBP ≥ 110 mmHg Baseline Serum Potassium > 5.0 mmol/L Patients who are treated with two renin-angiotensin-aldosterone-system-blockers Patients with NYHA class III or IV heart failure Known renal artery stenosis Previous randomization into the AVOID trial (CSPP100C2201) EXCLUSION SPECIFIC TO THE SAFETY FOLLOW-UP PERIOD: - Aliskiren or aliskiren containing fixed combination products must not be used Other protocol-defined inclusion/exclusion criteria applied

Overall Study Officials:

First Name & Middle Initial & Last Name & Degree

Novartis Pharmaceuticals

Organizational Affiliation

Novartis Pharmaceuticals

Official's Role

Study Director

First Name & Middle Initial & Last Name & Degree

Novartis

Organizational Affiliation

Novartis

Official's Role

Study Chair

Facility Information:

Facility Name

Novartis Investigative Site

City

Birmingham

State/Province

Alabama

ZIP/Postal Code

35209

Country

United States

Facility Name

Novartis Investigative Site

City

Birmingham

State/Province

Alabama

ZIP/Postal Code

35235

Country

United States

Facility Name

Novartis Investigative Site

City

Huntsville

State/Province

Alabama

ZIP/Postal Code

35801

Country

United States

Facility Name

Novartis Investigative Site

City

Mobile

State/Province

Alabama

ZIP/Postal Code

36608

Country

United States

Facility Name

Novartis Investigative Site

City

Mobile

State/Province

Alabama

ZIP/Postal Code

36617

Country

United States

Facility Name

Novartis Investigative Site

City

Montgomery

State/Province

Alabama

ZIP/Postal Code

36106

Country

United States

Facility Name

Novartis Investigative Site

City

Muscle Shoals

State/Province

Alabama

ZIP/Postal Code

35662

Country

United States

Facility Name

Novartis Investigative Site

City

Peoria

State/Province

Arizona

ZIP/Postal Code

85381

Country

United States

Facility Name

Novartis Investigative Site

City

Phoenix

State/Province

Arizona

ZIP/Postal Code

85032

Country

United States

Facility Name

Novartis Investigative Site

City

Tucson

State/Province

Arizona

ZIP/Postal Code

85712

Country

United States

Facility Name

Novartis Investigative Site

City

Tucson

State/Province

Arizona

ZIP/Postal Code

85741

Country

United States

Facility Name

Novartis Investigative Site

City

Fayetteville

State/Province

Arkansas

ZIP/Postal Code

72703

Country

United States

Facility Name

Novartis Investigative Site

City

Burlingame

State/Province

California

ZIP/Postal Code

94010

Country

United States

Facility Name

Novartis Investigative Site

City

Fullerton

State/Province

California

ZIP/Postal Code

92835

Country

United States

Facility Name

Novartis Investigative Site

City

Huntington Beach

State/Province

California

ZIP/Postal Code

92648

Country

United States

Facility Name

Novartis Investigative Site

City

Oakland

State/Province

California

ZIP/Postal Code

94609

Country

United States

Facility Name

Novartis Investigative Site

City

Pasadena

State/Province

California

ZIP/Postal Code

91101

Country

United States

Facility Name

Novartis Investigative Site

City

Riverside

State/Province

California

ZIP/Postal Code

92501

Country

United States

Facility Name

Novartis Investigative Site

City

Spring Valley

State/Province

California

ZIP/Postal Code

91978-1522

Country

United States

Facility Name

Novartis Investigative Site

City

Torrance

State/Province

California

ZIP/Postal Code

90502

Country

United States

Facility Name

Novartis Investigative Site

City

Walnut Creek

State/Province

California

ZIP/Postal Code

94598

Country

United States

Facility Name

Novartis Investigative Site

City

Denver

State/Province

Colorado

ZIP/Postal Code

80209

Country

United States

Facility Name

Novartis Investigative Site

City

Bridgeport

State/Province

Connecticut

ZIP/Postal Code

06610

Country

United States

Facility Name

Novartis Investigative Site

City

Aventura

State/Province

Florida

ZIP/Postal Code

33180

Country

United States

Facility Name

Novartis Investigative Site

City

Boca Raton

State/Province

Florida

ZIP/Postal Code

33433

Country

United States

Facility Name

Novartis Investigative Site

City

Ft. Lauderdale

State/Province

Florida

ZIP/Postal Code

33311

Country

United States

Facility Name

Novartis Investigative Site

City

Hollywood

State/Province

Florida

ZIP/Postal Code

33021

Country

United States

Facility Name

Novartis Investigative Site

City

Jacksonville

State/Province

Florida

ZIP/Postal Code

32204

Country

United States

Facility Name

Novartis Investigative Site

City

Jacksonville

State/Province

Florida

ZIP/Postal Code

32205

Country

United States

Facility Name

Novartis Investigative Site

City

Jacksonville

State/Province

Florida

ZIP/Postal Code

32209

Country

United States

Facility Name

Novartis Investigative Site

City

Jacksonville

State/Province

Florida

ZIP/Postal Code

32216

Country

United States

Facility Name

Novartis Investigative Site

City

Lauderdale Lakes

State/Province

Florida

ZIP/Postal Code

33313

Country

United States

Facility Name

Novartis Investigative Site

City

Pensacola

State/Province

Florida

ZIP/Postal Code

32504

Country

United States

Facility Name

Novartis Investigative Site

City

Plantation

State/Province

Florida

ZIP/Postal Code

33324

Country

United States

Facility Name

Novartis Investigative Site

City

West Palm Beach

State/Province

Florida

ZIP/Postal Code

33401

Country

United States

Facility Name

Novartis Investigative Site

City

Atlanta

State/Province

Georgia

ZIP/Postal Code

30309

Country

United States

Facility Name

Novartis Investigative Site

City

Augusta

State/Province

Georgia

ZIP/Postal Code

30904

Country

United States

Facility Name

Novartis Investigative Site

City

Augusta

State/Province

Georgia

ZIP/Postal Code

30909

Country

United States

Facility Name

Novartis Investigative Site

City

Cumming

State/Province

Georgia

ZIP/Postal Code

30041

Country

United States

Facility Name

Novartis Investigative Site

City

Honolulu

State/Province

Hawaii

ZIP/Postal Code

96813

Country

United States

Facility Name

Novartis Investigative Site

City

Honolulu

State/Province

Hawaii

ZIP/Postal Code

96814

Country

United States

Facility Name

Novartis Investigative Site

City

Champaign

State/Province

Illinois

ZIP/Postal Code

61820

Country

United States

Facility Name

Novartis Investigative Site

City

Lake Zurich

State/Province

Illinois

ZIP/Postal Code

60047

Country

United States

Facility Name

Novartis Investigative Site

City

Peoria

State/Province

Illinois

ZIP/Postal Code

61615

Country

United States

Facility Name

Novartis Investigative Site

City

Topeka

State/Province

Kansas

ZIP/Postal Code

66606

Country

United States

Facility Name

Novartis Investigative Site

City

Louisville

State/Province

Kentucky

ZIP/Postal Code

40202

Country

United States

Facility Name

Novartis Investigative Site

City

Metairie

State/Province

Louisiana

ZIP/Postal Code

70006

Country

United States

Facility Name

Novartis Investigative Site

City

Slidell

State/Province

Louisiana

ZIP/Postal Code

70458

Country

United States

Facility Name

Novartis Investigative Site

City

Baltimore

State/Province

Maryland

ZIP/Postal Code

21204

Country

United States

Facility Name

Novartis Investigative Site

City

Burlington

State/Province

Massachusetts

ZIP/Postal Code

01803

Country

United States

Facility Name

Novartis Investigative Site

City

Haverhill

State/Province

Massachusetts

ZIP/Postal Code

01830

Country

United States

Facility Name

Novartis Investigative Site

City

Jamaica Plain

State/Province

Massachusetts

ZIP/Postal Code

02130

Country

United States

Facility Name

Novartis Investigative Site

City

Natick

State/Province

Massachusetts

ZIP/Postal Code

01760

Country

United States

Facility Name

Novartis Investigative Site

City

North Dartmouth

State/Province

Massachusetts

ZIP/Postal Code

02747

Country

United States

Facility Name

Novartis Investigative Site

City

Waltham

State/Province

Massachusetts

ZIP/Postal Code

02154

Country

United States

Facility Name

Novartis Investigative Site

City

Worcester

State/Province

Massachusetts

ZIP/Postal Code

01609

Country

United States

Facility Name

Novartis Investigative Site

City

Ann Arbor

State/Province

Michigan

ZIP/Postal Code

48109

Country

United States

Facility Name

Novartis Investigative Site

City

Detroit

State/Province

Michigan

ZIP/Postal Code

48202

Country

United States

Facility Name

Novartis Investigative Site

City

Detroit

State/Province

Michigan

ZIP/Postal Code

48236

Country

United States

Facility Name

Novartis Investigative Site

City

Kalamazoo

State/Province

Michigan

ZIP/Postal Code

49048

Country

United States

Facility Name

Novartis Investigative Site

City

Livonia

State/Province

Michigan

ZIP/Postal Code

48154

Country

United States

Facility Name

Novartis Investigative Site

City

Minneapolis

State/Province

Minnesota

ZIP/Postal Code

55404

Country

United States

Facility Name

Novartis Investigative Site

City

Minneapolis

State/Province

Minnesota

ZIP/Postal Code

55455

Country

United States

Facility Name

Novartis Investigative Site

City

St. Louis Park

State/Province

Minnesota

ZIP/Postal Code

55416

Country

United States

Facility Name

Novartis Investigative Site

City

Belzoni

State/Province

Mississippi

ZIP/Postal Code

39038

Country

United States

Facility Name

Novartis Investigative Site

City

Gulfport

State/Province

Mississippi

ZIP/Postal Code

39501

Country

United States

Facility Name

Novartis Investigative Site

City

Jackson

State/Province

Mississippi

ZIP/Postal Code

39209

Country

United States

Facility Name

Novartis Investigative Site

City

Springfield

State/Province

Missouri

ZIP/Postal Code

65807

Country

United States

Facility Name

Novartis Investigative Site

City

St. Louis

State/Province

Missouri

ZIP/Postal Code

63110-1093

Country

United States

Facility Name

Novartis Investigative Site

City

St. Louis

State/Province

Missouri

ZIP/Postal Code

63141

Country

United States

Facility Name

Novartis Investigative Site

City

Fremont

State/Province

Nebraska

ZIP/Postal Code

68025

Country

United States

Facility Name

Novartis Investigative Site

City

Omaha

State/Province

Nebraska

ZIP/Postal Code

68131

Country

United States

Facility Name

Novartis Investigative Site

City

Dover

State/Province

New Hampshire

ZIP/Postal Code

03820-2403

Country

United States

Facility Name

Novartis Investigative Site

City

Princeton Junction

State/Province

New Jersey

ZIP/Postal Code

08550

Country

United States

Facility Name

Novartis Investigative Site

City

Albuquerque

State/Province

New Mexico

ZIP/Postal Code

87106

Country

United States

Facility Name

Novartis Investigative Site

City

Albany

State/Province

New York

ZIP/Postal Code

12206

Country

United States

Facility Name

Novartis Investigative Site

City

Rochester

State/Province

New York

ZIP/Postal Code

14607

Country

United States

Facility Name

Novartis Investigative Site

City

Cincinnati

State/Province

Ohio

ZIP/Postal Code

45236

Country

United States

Facility Name

Novartis Investigative Site

City

Cleveland

State/Province

Ohio

ZIP/Postal Code

44115

Country

United States

Facility Name

Novartis Investigative Site

City

Lyndhurst

State/Province

Ohio

ZIP/Postal Code

44124

Country

United States

Facility Name

Novartis Investigative Site

City

Norman

State/Province

Oklahoma

ZIP/Postal Code

73069

Country

United States

Facility Name

Novartis Investigative Site

City

Oklahoma City

State/Province

Oklahoma

ZIP/Postal Code

73112

Country

United States

Facility Name

Novartis Investigative Site

City

Tulsa

State/Province

Oklahoma

ZIP/Postal Code

74133

Country

United States

Facility Name

Novartis Investigative Site

City

Allentown

State/Province

Pennsylvania

ZIP/Postal Code

18103

Country

United States

Facility Name

Novartis Investigative Site

City

Lancaster

State/Province

Pennsylvania

ZIP/Postal Code

17604

Country

United States

Facility Name

Novartis Investigative Site

City

Lansdale

State/Province

Pennsylvania

ZIP/Postal Code

19446

Country

United States

Facility Name

Novartis Investigative Site

City

Melrose Park

State/Province

Pennsylvania

ZIP/Postal Code

19027

Country

United States

Facility Name

Novartis Investigative Site

City

Philadelphia

State/Province

Pennsylvania

ZIP/Postal Code

19138

Country

United States

Facility Name

Novartis Investigative Site

City

Wyomissing

State/Province

Pennsylvania

ZIP/Postal Code

19610

Country

United States

Facility Name

Novartis Investigative Site

City

Warwick

State/Province

Rhode Island

ZIP/Postal Code

02886

Country

United States

Facility Name

Novartis Investigative Site

City

Aiken

State/Province

South Carolina

ZIP/Postal Code

29801

Country

United States

Facility Name

Novartis Investigative Site

City

Charleston

State/Province

South Carolina

ZIP/Postal Code

29425

Country

United States

Facility Name

Novartis Investigative Site

City

Columbia

State/Province

South Carolina

ZIP/Postal Code

29201

Country

United States

Facility Name

Novartis Investigative Site

City

Greenville

State/Province

South Carolina

ZIP/Postal Code

29605

Country

United States

Facility Name

Novartis Investigative Site

City

Orangeburg

State/Province

South Carolina

ZIP/Postal Code

29115

Country

United States

Facility Name

Novartis Investigative Site

City

Collierville

State/Province

Tennessee

ZIP/Postal Code

38017

Country

United States

Facility Name

Novartis Investigative Site

City

Amarillo

State/Province

Texas

ZIP/Postal Code

79106

Country

United States

Facility Name

Novartis Investigative Site

City

Austin

State/Province

Texas

ZIP/Postal Code

78731

Country

United States

Facility Name

Novartis Investigative Site

City

Dallas

State/Province

Texas

ZIP/Postal Code

75226

Country

United States

Facility Name

Novartis Investigative Site

City

Dallas

State/Province

Texas

ZIP/Postal Code

75231

Country

United States

Facility Name

Novartis Investigative Site

City

Dallas

State/Province

Texas

ZIP/Postal Code

75235

Country

United States

Facility Name

Novartis Investigative Site

City

Dallas

State/Province

Texas

ZIP/Postal Code

75390

Country

United States

Facility Name

Novartis Investigative Site

City

Houston

State/Province

Texas

ZIP/Postal Code

77030

Country

United States

Facility Name

Novartis Investigative Site

City

Irving

State/Province

Texas

ZIP/Postal Code

75039

Country

United States

Facility Name

Novartis Investigative Site

City

McAllen

State/Province

Texas

ZIP/Postal Code

78501

Country

United States

Facility Name

Novartis Investigative Site

City

North Richland Hills

State/Province

Texas

ZIP/Postal Code

76180

Country

United States

Facility Name

Novartis Investigative Site

City

Plano

State/Province

Texas

ZIP/Postal Code

75024

Country

United States

Facility Name

Novartis Investigative Site

City

San Antonio

State/Province

Texas

ZIP/Postal Code

78207

Country

United States

Facility Name

Novartis Investigative Site

City

San Antonio

State/Province

Texas

ZIP/Postal Code

78218

Country

United States

Facility Name

Novartis Investigative Site

City

San Antonio

State/Province

Texas

ZIP/Postal Code

78229-4801

Country

United States

Facility Name

Novartis Investigative Site

City

Temple

State/Province

Texas

ZIP/Postal Code

76508-0002

Country

United States

Facility Name

Novartis Investigative Site

City

Bennington

State/Province

Vermont

ZIP/Postal Code

05201

Country

United States

Facility Name

Novartis Investigative Site

City

Burlington

State/Province

Vermont

ZIP/Postal Code

05401

Country

United States

Facility Name

Novartis Investigative Site

City

Alexandria

State/Province

Virginia

ZIP/Postal Code

22304-2315

Country

United States

Facility Name

Novartis Investigative Site

City

Burke

State/Province

Virginia

ZIP/Postal Code

22015

Country

United States

Facility Name

Novartis Investigative Site

City

Renton

State/Province

Washington

ZIP/Postal Code

98055

Country

United States

Facility Name

Novartis Investigative Site

City

Charleston

State/Province

West Virginia

ZIP/Postal Code

25301

Country

United States

Facility Name

Novartis Investigative Site

City

Appleton

State/Province

Wisconsin

ZIP/Postal Code

54911

Country

United States

Facility Name

Novartis Investigative Site

City

Caba

State/Province

Buenos Aires

ZIP/Postal Code

1428

Country

Argentina

Facility Name

Novartis Investigative Site

City

Caba

State/Province

Buenos Aires

ZIP/Postal Code

C1181ACH

Country

Argentina

Facility Name

Novartis Investigative Site

City

Caba

State/Province

Buenos Aires

ZIP/Postal Code

C1280AEB

Country

Argentina

Facility Name

Novartis Investigative Site

City

Caba

State/Province

Buenos Aires

ZIP/Postal Code

C1408INH

Country

Argentina

Facility Name

Novartis Investigative Site

City

Caba

State/Province

Buenos Aires

ZIP/Postal Code

C1416DRJ

Country

Argentina

Facility Name

Novartis Investigative Site

City

Caba

State/Province

Buenos Aires

ZIP/Postal Code

C1425AST

Country

Argentina

Facility Name

Novartis Investigative Site

City

Florida

State/Province

Buenos Aires

ZIP/Postal Code

B1602BPD

Country

Argentina

Facility Name

Novartis Investigative Site

City

Lanus

State/Province

Buenos Aires

ZIP/Postal Code

B8000XAV

Country

Argentina

Facility Name

Novartis Investigative Site

City

Ramos Mejia

State/Province

Buenos Aires

ZIP/Postal Code

B1704ETD

Country

Argentina

Facility Name

Novartis Investigative Site

City

Zarate

State/Province

Buenos Aires

ZIP/Postal Code

2800

Country

Argentina

Facility Name

Novartis Investigative Site

City

Rosario

State/Province

Santa Fe

ZIP/Postal Code

S2000AII

Country

Argentina

Facility Name

Novartis Investigative Site

City

Rosario

State/Province

Santa Fe

ZIP/Postal Code

S2000CXH

Country

Argentina

Facility Name

Novartis Investigative Site

City

Rosario

State/Province

Santa Fe

ZIP/Postal Code

S2000DFD

Country

Argentina

Facility Name

Novartis Investigative Site

City

Rosario

State/Province

Santa Fe

ZIP/Postal Code

S2001ODA

Country

Argentina

Facility Name

Novartis Investigative Site

City

Rosario

State/Province

Santa Fe

ZIP/Postal Code

S200CVD

Country

Argentina

Facility Name

Novartis Investigative Site

City

Buenos aires

ZIP/Postal Code

C1120AAC

Country

Argentina

Facility Name

Novartis Investigative Site

City

Buenos Aires

ZIP/Postal Code

C1405BCH

Country

Argentina

Facility Name

Novartis Investigative Site

City

Cordoba

ZIP/Postal Code

5000

Country

Argentina

Facility Name

Novartis Investigative Site

City

Cordoba

ZIP/Postal Code

X5000AAW

Country

Argentina

Facility Name

Novartis Investigative Site

City

Cordoba

ZIP/Postal Code

X5000EVQ

Country

Argentina

Facility Name

Novartis Investigative Site

City

Cordoba

ZIP/Postal Code

X5000FGG

Country

Argentina

Facility Name

Novartis Investigative Site

City

Cordoba

ZIP/Postal Code

X5000IUG

Country

Argentina

Facility Name

Novartis Investigative Site

City

Cordoba

ZIP/Postal Code

X5000JHQ

Country

Argentina

Facility Name

Novartis Investigative Site

City

Cordoba

ZIP/Postal Code

X5009BSN

Country

Argentina

Facility Name

Novartis Investigative Site

City

Cordoba

ZIP/Postal Code

X5016KEH

Country

Argentina

Facility Name

Novartis Investigative Site

City

Corrientes

ZIP/Postal Code

W3400

Country

Argentina

Facility Name

Novartis Investigative Site

City

Santa Fe

ZIP/Postal Code

S3000FNF

Country

Argentina

Facility Name

Novartis Investigative Site

City

Santa Fe

ZIP/Postal Code

S3000FSO

Country

Argentina

Facility Name

Novartis Investigative Site

City

Santa Fe

ZIP/Postal Code

S3000FVA

Country

Argentina

Facility Name

Novartis Investigative Site

City

Bregenz

ZIP/Postal Code

A-6900

Country

Austria

Facility Name

Novartis Investigative Site

City

Feldkirch

ZIP/Postal Code

6807

Country

Austria

Facility Name

Novartis Investigative Site

City

Graz

ZIP/Postal Code

8036

Country

Austria

Facility Name

Novartis Investigative Site

City

Innsbruck

ZIP/Postal Code

INNSBRUCK

Country

Austria

Facility Name

Novartis Investigative Site

City

Salzburg

ZIP/Postal Code

A-5020

Country

Austria

Facility Name

Novartis Investigative Site

City

Vienna

ZIP/Postal Code

1030

Country

Austria

Facility Name

Novartis Investigative Site

City

Wien

ZIP/Postal Code

1090

Country

Austria

Facility Name

Novartis Investigative Site

City

Wien

ZIP/Postal Code

A-1130

Country

Austria

Facility Name

Novartis Investigative Site

City

Wien

ZIP/Postal Code

A-1220

Country

Austria

Facility Name

Novartis Investigative Site

City

Bonheiden

ZIP/Postal Code

2820

Country

Belgium

Facility Name

Novartis Investigative Site

City

Brugge

ZIP/Postal Code

8000

Country

Belgium

Facility Name

Novartis Investigative Site

City

Brussel

ZIP/Postal Code

9100

Country

Belgium

Facility Name

Novartis Investigative Site

City

Bruxelles

ZIP/Postal Code

1070

Country

Belgium

Facility Name

Novartis Investigative Site

City

Bruxelles

ZIP/Postal Code

1200

Country

Belgium

Facility Name

Novartis Investigative Site

City

Charleroi

ZIP/Postal Code

6000

Country

Belgium

Facility Name

Novartis Investigative Site

City

De Pinte

ZIP/Postal Code

9840

Country

Belgium

Facility Name

Novartis Investigative Site

City

Edegem

ZIP/Postal Code

2650

Country

Belgium

Facility Name

Novartis Investigative Site

City

Genk

ZIP/Postal Code

3600

Country

Belgium

Facility Name

Novartis Investigative Site

City

Gent

ZIP/Postal Code

9000

Country

Belgium

Facility Name

Novartis Investigative Site

City

Hasselt

ZIP/Postal Code

3500

Country

Belgium

Facility Name

Novartis Investigative Site

City

Kortrijk

ZIP/Postal Code

8500

Country

Belgium

Facility Name

Novartis Investigative Site

City

La Louvière

ZIP/Postal Code

7100

Country

Belgium

Facility Name

Novartis Investigative Site

City

Leuven

ZIP/Postal Code

3000

Country

Belgium

Facility Name

Novartis Investigative Site

City

Liege

ZIP/Postal Code

4000

Country

Belgium

Facility Name

Novartis Investigative Site

City

Roeselare

ZIP/Postal Code

8800

Country

Belgium

Facility Name

Novartis Investigative Site

City

Ronse

ZIP/Postal Code

9600

Country

Belgium

Facility Name

Novartis Investigative Site

City

Seraing

ZIP/Postal Code

4100

Country

Belgium

Facility Name

Novartis Investigative Site

City

Sint-Gillis-Waas

ZIP/Postal Code

9170

Country

Belgium

Facility Name

Novartis Investigative Site

City

Turnhout

ZIP/Postal Code

2300

Country

Belgium

Facility Name

Novartis Investigative Site

City

Vilvoorde

ZIP/Postal Code

1800

Country

Belgium

Facility Name

Novartis Investigative Site

City

Willebroek

ZIP/Postal Code

2830

Country

Belgium

Facility Name

Novartis Investigative Site

City

Salvador

State/Province

ZIP/Postal Code

40050-410

Country

Brazil

Facility Name

Novartis Investigative Site

City

Fortaleza

State/Province

ZIP/Postal Code

60120-021

Country

Brazil

Facility Name

Novartis Investigative Site

City

Fortaleza

State/Province

ZIP/Postal Code

60430-370

Country

Brazil

Facility Name

Novartis Investigative Site

City

Vitoria

State/Province

ZIP/Postal Code

29040-091

Country

Brazil

Facility Name

Novartis Investigative Site

City

Juiz de Fora

State/Province

ZIP/Postal Code

36036-110

Country

Brazil

Facility Name

Novartis Investigative Site

City

Belem

State/Province

ZIP/Postal Code

66073-000

Country

Brazil

Facility Name

Novartis Investigative Site

City

Rio de Janeiro

State/Province

ZIP/Postal Code

20020-020

Country

Brazil

Facility Name

Novartis Investigative Site

City

Rio de Janeiro

State/Province

ZIP/Postal Code

20551-030

Country

Brazil

Facility Name

Novartis Investigative Site

City

Porto Alegre

State/Province

ZIP/Postal Code

90020-090

Country

Brazil

Facility Name

Novartis Investigative Site

City

Campinas

State/Province

ZIP/Postal Code

13060-904

Country

Brazil

Facility Name

Novartis Investigative Site

City

Campinas

State/Province

ZIP/Postal Code

13083-190

Country

Brazil

Facility Name

Novartis Investigative Site

City

Marilia

State/Province

ZIP/Postal Code

17519-030

Country

Brazil

Facility Name

Novartis Investigative Site

City

Santos

State/Province

ZIP/Postal Code

11045-904

Country

Brazil

Facility Name

Novartis Investigative Site

City

Sao Jose do Rio Preto

State/Province

ZIP/Postal Code

15090-000

Country

Brazil

Facility Name

Novartis Investigative Site

City

Sorocaba

State/Province

ZIP/Postal Code

18030-210

Country

Brazil

Facility Name

Novartis Investigative Site

City

São Paulo

State/Province

ZIP/Postal Code

04023-900

Country

Brazil

Facility Name

Novartis Investigative Site

City

São Paulo

State/Province

ZIP/Postal Code

05403-000

Country

Brazil

Facility Name

Novartis Investigative Site

City

Edmonton

State/Province

Alberta

ZIP/Postal Code

T5J 3N4

Country

Canada

Facility Name

Novartis Investigative Site

City

Edmonton

State/Province

Alberta

ZIP/Postal Code

T5N 3Y6

Country

Canada

Facility Name

Novartis Investigative Site

City

Vancouver

State/Province

British Columbia

ZIP/Postal Code

V6E 1M7

Country

Canada

Facility Name

Novartis Investigative Site

City

Winnipeg

State/Province

Manitoba

ZIP/Postal Code

R2V 4W3

Country

Canada

Facility Name

Novartis Investigative Site

City

Winnipeg

State/Province

Manitoba

ZIP/Postal Code

R3E 3P4

Country

Canada

Facility Name

Novartis Investigative Site

City

Bay Roberts

State/Province

Newfoundland and Labrador

ZIP/Postal Code

A0A 1G0

Country

Canada

Facility Name

Novartis Investigative Site

City

St. John's

State/Province

Newfoundland and Labrador

ZIP/Postal Code

A1E 4J8

Country

Canada

Facility Name

Novartis Investigative Site

City

Brampton

State/Province

Ontario

ZIP/Postal Code

L6Z 4N5

Country

Canada

Facility Name

Novartis Investigative Site

City

Burlington

State/Province

Ontario

ZIP/Postal Code

L7M 4Y1

Country

Canada

Facility Name

Novartis Investigative Site

City

Cambridge

State/Province

Ontario

ZIP/Postal Code

N1R 6V6

Country

Canada

Facility Name

Novartis Investigative Site

City

Courtice

State/Province

Ontario

ZIP/Postal Code

L1E 3C3

Country

Canada

Facility Name

Novartis Investigative Site

City

Etobicoke

State/Province

Ontario

ZIP/Postal Code

M9R 4E1

Country

Canada

Facility Name

Novartis Investigative Site

City

London

State/Province

Ontario

ZIP/Postal Code

N6A 4G5

Country

Canada

Facility Name

Novartis Investigative Site

City

North Bay

State/Province

Ontario

ZIP/Postal Code

P1B 2H3

Country

Canada

Facility Name

Novartis Investigative Site

City

Oakville

State/Province

Ontario

ZIP/Postal Code

L6H 3P1

Country

Canada

Facility Name

Novartis Investigative Site

City

Oshawa

State/Province

Ontario

ZIP/Postal Code

L1J 2K1

Country

Canada

Facility Name

Novartis Investigative Site

City

Ottawa

State/Province

Ontario

ZIP/Postal Code

K1H 7W9

Country

Canada

Facility Name

Novartis Investigative Site

City

Scarborough

State/Province

Ontario

ZIP/Postal Code

M1H 3G4

Country

Canada

Facility Name

Novartis Investigative Site

City

Thornhill

State/Province

Ontario

ZIP/Postal Code

L4J 8L7

Country

Canada

Facility Name

Novartis Investigative Site

City

Toronto

State/Province

Ontario

ZIP/Postal Code

M4G 3E8

Country

Canada

Facility Name

Novartis Investigative Site

City

Toronto

State/Province

Ontario

ZIP/Postal Code

M4N 3M5

Country

Canada

Facility Name

Novartis Investigative Site

City

Toronto

State/Province

Ontario

ZIP/Postal Code

M5C 2T2

Country

Canada

Facility Name

Novartis Investigative Site

City

Toronto

State/Province

Ontario

ZIP/Postal Code

N6G 4X8

Country

Canada

Facility Name

Novartis Investigative Site

City

Greenfield Park

State/Province

Quebec

ZIP/Postal Code

J4V 2H1

Country

Canada

Facility Name

Novartis Investigative Site

City

Mirabel

State/Province

Quebec

ZIP/Postal Code

J7J 2K8

Country

Canada

Facility Name

Novartis Investigative Site

City

Montreal

State/Province

Quebec

ZIP/Postal Code

H1T 2M4

Country

Canada

Facility Name

Novartis Investigative Site

City

Pointe-Claire

State/Province

Quebec

ZIP/Postal Code

H9R 4S3

Country

Canada

Facility Name

Novartis Investigative Site

City

Québec

State/Province

Quebec

ZIP/Postal Code

G1G 3Y8

Country

Canada

Facility Name

Novartis Investigative Site

City

Sainte-Foy

State/Province

Quebec

ZIP/Postal Code

G1V 4G5

Country

Canada

Facility Name

Novartis Investigative Site

City

Sainte-Foy

State/Province

Quebec

ZIP/Postal Code

G1W 4R4

Country

Canada

Facility Name

Novartis Investigative Site

City

Sherbrooke

State/Province

Quebec

ZIP/Postal Code

J1G 5K2

Country

Canada

Facility Name

Novartis Investigative Site

City

Ste-Foy

State/Province

Quebec

ZIP/Postal Code

G1V 4G2

Country

Canada

Facility Name

Novartis Investigative Site

City

Trois-Rivières

State/Province

Quebec

ZIP/Postal Code

G8Z 3R9

Country

Canada

Facility Name

Novartis Investigative Site

City

Saskatoon

State/Province

Saskatchewan

ZIP/Postal Code

S7H 5M3

Country

Canada

Facility Name

Novartis Investigative Site

City

Ouest-Montreal

ZIP/Postal Code

H2W1R7

Country

Canada

Facility Name

Novartis Investigative Site

City

Beijing

State/Province

Beijing

ZIP/Postal Code

100044

Country

China

Facility Name

Novartis Investigative Site

City

Beijing

State/Province

Beijing

ZIP/Postal Code

100083

Country

China

Facility Name

Novartis Investigative Site

City

Beijing

State/Province

Beijing

ZIP/Postal Code

100730

Country

China

Facility Name

Novartis Investigative Site

City

Chongqing

State/Province

Chongqing

ZIP/Postal Code

400016

Country

China

Facility Name

Novartis Investigative Site

City

Chongqing

State/Province

Chongqing

Country

China

Facility Name

Novartis Investigative Site

City

Fuzhou

State/Province

Fujian

ZIP/Postal Code

350025

Country

China

Facility Name

Novartis Investigative Site

City

Guangzhou

State/Province

Guangdong

ZIP/Postal Code

510180

Country

China

Facility Name

Novartis Investigative Site

City

Shijiazhuang

State/Province

Hebei

ZIP/Postal Code

050051

Country

China

Facility Name

Novartis Investigative Site

City

Harbin

State/Province

Heilongjiang

ZIP/Postal Code

150001

Country

China

Facility Name

Novartis Investigative Site

City

Harbin

State/Province

Heilongjiang

ZIP/Postal Code

150086

Country

China

Facility Name

Novartis Investigative Site

City

Wuhan

State/Province

Hubei

ZIP/Postal Code

430030

Country

China

Facility Name

Novartis Investigative Site

City

Changsha City

State/Province

Hunan

ZIP/Postal Code

410011

Country

China

Facility Name

Novartis Investigative Site

City

Changsha

State/Province

Hunan

ZIP/Postal Code

410008

Country

China

Facility Name

Novartis Investigative Site

City

Nanjing

State/Province

Jiangsu

ZIP/Postal Code

210006

Country

China

Facility Name

Novartis Investigative Site

City

Nanjing

State/Province

Jiangsu

ZIP/Postal Code

210008

Country

China

Facility Name

Novartis Investigative Site

City

Nanjing

State/Province

Jiangsu

ZIP/Postal Code

210009

Country

China

Facility Name

Novartis Investigative Site

City

Nanjing

State/Province

Jiangsu

ZIP/Postal Code

210029

Country

China

Facility Name

Novartis Investigative Site

City

Suzhou

State/Province

Jiangsu

ZIP/Postal Code

215004

Country

China

Facility Name

Novartis Investigative Site

City

Dalian

State/Province

Liaoning

ZIP/Postal Code

116011

Country

China

Facility Name

Novartis Investigative Site

City

Shenyang

State/Province

Liaoning

ZIP/Postal Code

110003

Country

China

Facility Name

Novartis Investigative Site

City

Qingdao

State/Province

Shandong

ZIP/Postal Code

266011

Country

China

Facility Name

Novartis Investigative Site

City

Xi'an

State/Province

Shanxi

ZIP/Postal Code

710032

Country

China

Facility Name

Novartis Investigative Site

City

Xi'an

State/Province

Shanxi

ZIP/Postal Code

710061

Country

China

Facility Name

Novartis Investigative Site

City

Chengdu

State/Province

Sichuan

ZIP/Postal Code

610041

Country

China

Facility Name

Novartis Investigative Site

City

Kunming

State/Province

Yunnan

ZIP/Postal Code

650101

Country

China

Facility Name

Novartis Investigative Site

City

Hangzhou

State/Province

Zhejiang

ZIP/Postal Code

310003

Country

China

Facility Name

Novartis Investigative Site

City

Hangzhou

State/Province

Zhejiang

ZIP/Postal Code

310009

Country

China

Facility Name

Novartis Investigative Site

City

Hangzhou

State/Province

Zhejiang

ZIP/Postal Code

310013

Country

China

Facility Name

Novartis Investigative Site

City

Hangzhou

State/Province

Zhejiang

ZIP/Postal Code

310016

Country

China

Facility Name

Novartis Investigative Site

City

Beijing

ZIP/Postal Code

100028

Country

China

Facility Name

Novartis Investigative Site

City

Beijing

ZIP/Postal Code

100029

Country

China

Facility Name

Novartis Investigative Site

City

Beijing

ZIP/Postal Code

100034

Country

China

Facility Name

Novartis Investigative Site

City

Beijing

ZIP/Postal Code

100088

Country

China

Facility Name

Novartis Investigative Site

City

Beijing

ZIP/Postal Code

100176

Country

China

Facility Name

Novartis Investigative Site

City

Beijing

Country

China

Facility Name

Novartis Investigative Site

City

Chengdu

ZIP/Postal Code

610072

Country

China

Facility Name

Novartis Investigative Site

City

Chongqing

ZIP/Postal Code

400038

Country

China

Facility Name

Novartis Investigative Site

City

Dalian

Country

China

Facility Name

Novartis Investigative Site

City

Guangzhou

ZIP/Postal Code

510000

Country

China

Facility Name

Novartis Investigative Site

City

Shanghai

ZIP/Postal Code

200003

Country

China

Facility Name

Novartis Investigative Site

City

Shanghai

ZIP/Postal Code

200025

Country

China

Facility Name

Novartis Investigative Site

City

Shanghai

ZIP/Postal Code

200031

Country

China

Facility Name

Novartis Investigative Site

City

Shanghai

ZIP/Postal Code

200233

Country

China

Facility Name

Novartis Investigative Site

City

Tianjin

ZIP/Postal Code

300052

Country

China

Facility Name

Novartis Investigative Site

City

Tianjin

ZIP/Postal Code

300142

Country

China

Facility Name

Novartis Investigative Site

City

Bogotá

Country

Colombia

Facility Name

Novartis Investigative Site

City

Cali

Country

Colombia

Facility Name

Novartis Investigative Site

City

Florida Blanca

Country

Colombia

Facility Name

Novartis Investigative Site

City

Medellín

Country

Colombia

Facility Name

Novartis Investigative Site

City

Brno-Bohunice

ZIP/Postal Code

639 01

Country

Czech Republic

Facility Name

Novartis Investigative Site

City

Brno

ZIP/Postal Code

61300

Country

Czech Republic

Facility Name

Novartis Investigative Site

City

Ceske Budejovice

ZIP/Postal Code

370 87

Country

Czech Republic

Facility Name

Novartis Investigative Site

City

Ostrava

ZIP/Postal Code

702 00

Country

Czech Republic

Facility Name

Novartis Investigative Site

City

Pardubice

ZIP/Postal Code

53002

Country

Czech Republic

Facility Name

Novartis Investigative Site

City

Pisek

ZIP/Postal Code

397 01

Country

Czech Republic

Facility Name

Novartis Investigative Site

City

Prague 2

ZIP/Postal Code

128 02

Country

Czech Republic

Facility Name

Novartis Investigative Site

City

Prague 2

ZIP/Postal Code

128 08

Country

Czech Republic

Facility Name

Novartis Investigative Site

City

Prague 4 - Krc

ZIP/Postal Code

14059

Country

Czech Republic

Facility Name

Novartis Investigative Site

City

Prague 5 - Motol

ZIP/Postal Code

15112

Country

Czech Republic

Facility Name

Novartis Investigative Site

City

Aalborg

ZIP/Postal Code

DK-9100

Country

Denmark

Facility Name

Novartis Investigative Site

City

Copenhagen NV

ZIP/Postal Code

DK-2400

Country

Denmark

Facility Name

Novartis Investigative Site

City

Frederiksberg

ZIP/Postal Code

DK-2000

Country

Denmark

Facility Name

Novartis Investigative Site

City

Gentofte

ZIP/Postal Code

DK-2820

Country

Denmark

Facility Name

Novartis Investigative Site

City

Hillerød

ZIP/Postal Code

DK-3400

Country

Denmark

Facility Name

Novartis Investigative Site

City

Hvidovre

ZIP/Postal Code

2650

Country

Denmark

Facility Name

Novartis Investigative Site

City

Roskilde

ZIP/Postal Code

DK-4000

Country

Denmark

Facility Name

Novartis Investigative Site

City

Slagelse

ZIP/Postal Code

DK-4200

Country

Denmark

Facility Name

Novartis Investigative Site

City

Svendborg

ZIP/Postal Code

DK-5700

Country

Denmark

Facility Name

Novartis Investigative Site

City

Århus

ZIP/Postal Code

DK-8000

Country

Denmark

Facility Name

Novartis Investigative Site

City

Helsinki

ZIP/Postal Code

00250

Country

Finland

Facility Name

Novartis Investigative Site

City

Hyvinkää

ZIP/Postal Code

FIN-05850

Country

Finland

Facility Name

Novartis Investigative Site

City

Kajaani

ZIP/Postal Code

FIN-87140

Country

Finland

Facility Name

Novartis Investigative Site

City

Kuopio

ZIP/Postal Code

FIN-70211

Country

Finland

Facility Name

Novartis Investigative Site

City

Lohja

ZIP/Postal Code

FIN-08200

Country

Finland

Facility Name

Novartis Investigative Site

City

Oulu

ZIP/Postal Code

90100

Country

Finland

Facility Name

Novartis Investigative Site

City

OYS

ZIP/Postal Code

FIN-90029

Country

Finland

Facility Name

Novartis Investigative Site

City

Pori

ZIP/Postal Code

28120

Country

Finland

Facility Name

Novartis Investigative Site

City

Tammisaari

ZIP/Postal Code

10600

Country

Finland

Facility Name

Novartis Investigative Site

City

Tampere

ZIP/Postal Code

33520

Country

Finland

Facility Name

Novartis Investigative Site

City

Valkeakoski

ZIP/Postal Code

37600

Country

Finland

Facility Name

Novartis Investigative Site

City

Besancon Cedex

ZIP/Postal Code

25030

Country

France

Facility Name

Novartis Investigative Site

City

Bondy

ZIP/Postal Code

93143

Country

France

Facility Name

Novartis Investigative Site

City

Corbeil Essonnes

ZIP/Postal Code

91100

Country

France

Facility Name

Novartis Investigative Site

City

Grenoble

ZIP/Postal Code

38043

Country

France

Facility Name

Novartis Investigative Site

City

La Rochelle

ZIP/Postal Code

17019

Country

France

Facility Name

Novartis Investigative Site

City

Lagny sur Marne

ZIP/Postal Code

77405

Country

France

Facility Name

Novartis Investigative Site

City

Limoges Cedex

ZIP/Postal Code

87042

Country

France

Facility Name

Novartis Investigative Site

City

Lyon Cedex 03

ZIP/Postal Code

69394

Country

France

Facility Name

Novartis Investigative Site

City

Lyon

ZIP/Postal Code

69437

Country

France

Facility Name

Novartis Investigative Site

City

Paris cedex 18

ZIP/Postal Code

75877

Country

France

Facility Name

Novartis Investigative Site

City

Paris Cedex 4

ZIP/Postal Code

75181

Country

France

Facility Name

Novartis Investigative Site

City

Poitiers Cedex

ZIP/Postal Code

86021

Country

France

Facility Name

Novartis Investigative Site

City

Aschaffenburg

ZIP/Postal Code

63739

Country

Germany

Facility Name

Novartis Investigative Site

City

Aschaffenburg

ZIP/Postal Code

63741

Country

Germany

Facility Name

Novartis Investigative Site

City

Asslar

ZIP/Postal Code

35614

Country

Germany

Facility Name

Novartis Investigative Site

City

Bad Oeynhausen

ZIP/Postal Code

32545

Country

Germany

Facility Name

Novartis Investigative Site

City

Barsinghausen

ZIP/Postal Code

30890

Country

Germany

Facility Name

Novartis Investigative Site

City

Bensheim

ZIP/Postal Code

64625

Country

Germany

Facility Name

Novartis Investigative Site

City

Berlin

ZIP/Postal Code

13055

Country

Germany

Facility Name

Novartis Investigative Site

City

Berlin

ZIP/Postal Code

13597

Country

Germany

Facility Name

Novartis Investigative Site

City

Berlin

ZIP/Postal Code

14193

Country

Germany

Facility Name

Novartis Investigative Site

City

Bonn

ZIP/Postal Code

53105

Country

Germany

Facility Name

Novartis Investigative Site

City

Bottrop

ZIP/Postal Code

46242

Country

Germany

Facility Name

Novartis Investigative Site

City

Bremen

ZIP/Postal Code

28277

Country

Germany

Facility Name

Novartis Investigative Site

City

Bretten

ZIP/Postal Code

75015

Country

Germany

Facility Name

Novartis Investigative Site

City

Cloppenburg

ZIP/Postal Code

49661

Country

Germany

Facility Name

Novartis Investigative Site

City

Dippoldiswalde

ZIP/Postal Code

01744

Country

Germany

Facility Name

Novartis Investigative Site

City

Dresden

ZIP/Postal Code

01127

Country

Germany

Facility Name

Novartis Investigative Site

City

Dresden

ZIP/Postal Code

01307

Country

Germany

Facility Name

Novartis Investigative Site

City

Duesseldorf

ZIP/Postal Code

40210

Country

Germany

Facility Name

Novartis Investigative Site

City

Essen

ZIP/Postal Code

45127

Country

Germany

Facility Name

Novartis Investigative Site

City

Essen

ZIP/Postal Code

45134

Country

Germany

Facility Name

Novartis Investigative Site

City

Essen

ZIP/Postal Code

45138

Country

Germany

Facility Name

Novartis Investigative Site

City

Fuldatal

ZIP/Postal Code

34233

Country

Germany

Facility Name

Novartis Investigative Site

City

Göttingen

ZIP/Postal Code

37075

Country

Germany

Facility Name

Novartis Investigative Site

City

Hagen

ZIP/Postal Code

58095

Country

Germany

Facility Name

Novartis Investigative Site

City

Hamburg

ZIP/Postal Code

22335

Country

Germany

Facility Name

Novartis Investigative Site

City

Hamburg

ZIP/Postal Code

22393

Country

Germany

Facility Name

Novartis Investigative Site

City

Hannover

ZIP/Postal Code

30625

Country

Germany

Facility Name

Novartis Investigative Site

City

Heidelberg

ZIP/Postal Code

69120

Country

Germany

Facility Name

Novartis Investigative Site

City

Heilbronn

ZIP/Postal Code

74072

Country

Germany

Facility Name

Novartis Investigative Site

City

Heilbronn

ZIP/Postal Code

74076

Country

Germany

Facility Name

Novartis Investigative Site

City

Ingelheim

ZIP/Postal Code

55218

Country

Germany

Facility Name

Novartis Investigative Site

City

Jena

ZIP/Postal Code

07743

Country

Germany

Facility Name

Novartis Investigative Site

City

Kassel

ZIP/Postal Code

34117

Country

Germany

Facility Name

Novartis Investigative Site

City

Krefeld

ZIP/Postal Code

47798

Country

Germany

Facility Name

Novartis Investigative Site

City

Magdeburg

ZIP/Postal Code

39120

Country

Germany

Facility Name

Novartis Investigative Site

City

Mainz

ZIP/Postal Code

55131

Country

Germany

Facility Name

Novartis Investigative Site

City

Messkirch

ZIP/Postal Code

88605

Country

Germany

Facility Name

Novartis Investigative Site

City

Muehldorf am Inn

ZIP/Postal Code

84453

Country

Germany

Facility Name

Novartis Investigative Site

City

Neuwied

ZIP/Postal Code

56564

Country

Germany

Facility Name

Novartis Investigative Site

City

Offenbach

ZIP/Postal Code

63065

Country

Germany

Facility Name

Novartis Investigative Site

City

Rehburg-Loccum

ZIP/Postal Code

31547

Country

Germany

Facility Name

Novartis Investigative Site

City

Riesa

ZIP/Postal Code

01587

Country

Germany

Facility Name

Novartis Investigative Site

City

Schauenburg-Elgershausen

ZIP/Postal Code

34270

Country

Germany

Facility Name

Novartis Investigative Site

City

Schwabenheim

ZIP/Postal Code

55270

Country

Germany

Facility Name

Novartis Investigative Site

City

St. Ingbert - Oberwuerzbach

ZIP/Postal Code

66386

Country

Germany

Facility Name

Novartis Investigative Site

City

Ursensollen

ZIP/Postal Code

92289

Country

Germany

Facility Name

Novartis Investigative Site

City

Wetter

ZIP/Postal Code

58300

Country

Germany

Facility Name

Novartis Investigative Site

City

Wiehl

ZIP/Postal Code

51674

Country

Germany

Facility Name

Novartis Investigative Site

City

Wiesbaden

ZIP/Postal Code

65183

Country

Germany

Facility Name

Novartis Investigative Site

City

Wuerzburg

ZIP/Postal Code

97072

Country

Germany

Facility Name

Novartis Investigative Site

City

Alexandroupolis

ZIP/Postal Code

GR 68 100

Country

Greece

Facility Name

Novartis Investigative Site

City

Athens - GR

ZIP/Postal Code

10676

Country

Greece

Facility Name

Novartis Investigative Site

City

Athens

ZIP/Postal Code

GR 115 21

Country

Greece

Facility Name

Novartis Investigative Site

City

Athens

ZIP/Postal Code

GR 115 22

Country

Greece

Facility Name

Novartis Investigative Site

City

Athens

ZIP/Postal Code

GR 115 27

Country

Greece

Facility Name

Novartis Investigative Site

City

Athens

ZIP/Postal Code

GR 11527

Country

Greece

Facility Name

Novartis Investigative Site

City

Athens

Country

Greece

Facility Name

Novartis Investigative Site

City

Ioannina

ZIP/Postal Code

GR 45500

Country

Greece

Facility Name

Novartis Investigative Site

City

Patras

ZIP/Postal Code

26500

Country

Greece

Facility Name

Novartis Investigative Site

City

Piraeurs

ZIP/Postal Code

GR 184 54

Country

Greece

Facility Name

Novartis Investigative Site

City

Thessaloniki

ZIP/Postal Code

57001

Country

Greece

Facility Name

Novartis Investigative Site

City

Thessaloniki

ZIP/Postal Code

GR 546 39

Country

Greece

Facility Name

Novartis Investigative Site

City

Guatemala City

ZIP/Postal Code

01001

Country

Guatemala

Facility Name

Novartis Investigative Site

City

Guatemala City

ZIP/Postal Code

01010

Country

Guatemala

Facility Name

Novartis Investigative Site

City

Guatemala City

ZIP/Postal Code

01011

Country

Guatemala

Facility Name

Novartis Investigative Site

City

Guatemala City

ZIP/Postal Code

01015

Country

Guatemala

Facility Name

Novartis Investigative Site

City

Baja

ZIP/Postal Code

6500

Country

Hungary

Facility Name

Novartis Investigative Site

City

Balatonfured

ZIP/Postal Code

8230

Country

Hungary

Facility Name

Novartis Investigative Site

City

Budapest

ZIP/Postal Code

1062

Country

Hungary

Facility Name

Novartis Investigative Site

City

Budapest

ZIP/Postal Code

1083

Country

Hungary

Facility Name

Novartis Investigative Site

City

Budapest

ZIP/Postal Code

1085

Country

Hungary

Facility Name

Novartis Investigative Site

City

Budapest

ZIP/Postal Code

1096

Country

Hungary

Facility Name

Novartis Investigative Site

City

Budapest

ZIP/Postal Code

1115

Country

Hungary

Facility Name

Novartis Investigative Site

City

Budapest

ZIP/Postal Code

H-1032

Country

Hungary

Facility Name

Novartis Investigative Site

City

Debrecen

ZIP/Postal Code

4004

Country

Hungary

Facility Name

Novartis Investigative Site

City

Debrecen

ZIP/Postal Code

4032

Country

Hungary

Facility Name

Novartis Investigative Site

City

Gyula

ZIP/Postal Code

5703

Country

Hungary

Facility Name

Novartis Investigative Site

City

Kaposvar

ZIP/Postal Code

7400

Country

Hungary

Facility Name

Novartis Investigative Site

City

Miskolc

ZIP/Postal Code

3526

Country

Hungary

Facility Name

Novartis Investigative Site

City

Pecs

ZIP/Postal Code

7324

Country

Hungary

Facility Name

Novartis Investigative Site

City

Szeged

ZIP/Postal Code

6720

Country

Hungary

Facility Name

Novartis Investigative Site

City

Zalaegerszeg

ZIP/Postal Code

8900

Country

Hungary

Facility Name

Novartis Investigative Site

City

Hyderabad

State/Province

Andhra Pradesh, INDIA

ZIP/Postal Code

500034

Country

India

Facility Name

Novartis Investigative Site

City

Hyderabad

State/Province

Andhra Pradesh

ZIP/Postal Code

500001

Country

India

Facility Name

Novartis Investigative Site

City

Hyderabad

State/Province

Andhra Pradesh

ZIP/Postal Code

500012

Country

India

Facility Name

Novartis Investigative Site

City

Hyderabad

State/Province

Andhra Pradesh

ZIP/Postal Code

500018

Country

India

Facility Name

Novartis Investigative Site

City

Ahmedabad

State/Province

Gujarat

ZIP/Postal Code

380014

Country

India

Facility Name

Novartis Investigative Site

City

Bangalore

State/Province

Karnataka

ZIP/Postal Code

560054

Country

India

Facility Name

Novartis Investigative Site

City

Banglaore

State/Province

Karnataka

ZIP/Postal Code

560038

Country

India

Facility Name

Novartis Investigative Site

City

Mangalore

State/Province

Karnataka

ZIP/Postal Code

575001

Country

India

Facility Name

Novartis Investigative Site

City

Kochi

State/Province

Kerala

ZIP/Postal Code

682 026

Country

India

Facility Name

Novartis Investigative Site

City

Mumbai

State/Province

Maharashtra

ZIP/Postal Code

400008

Country

India

Facility Name

Novartis Investigative Site

City

Pune

State/Province

Maharashtra

ZIP/Postal Code

411011

Country

India

Facility Name

Novartis Investigative Site

City

Pune

State/Province

Maharashtra

ZIP/Postal Code

411030

Country

India

Facility Name

Novartis Investigative Site

City

Chennai

State/Province

Tamil Nadu

ZIP/Postal Code

600013

Country

India

Facility Name

Novartis Investigative Site

City

Vellore

State/Province

Tamil Nadu

ZIP/Postal Code

632004

Country

India

Facility Name

Novartis Investigative Site

City

Bangalore

ZIP/Postal Code

560 034

Country

India

Facility Name

Novartis Investigative Site

City

Chennai

ZIP/Postal Code

600010

Country

India

Facility Name

Novartis Investigative Site

City

Chennai

ZIP/Postal Code

600086

Country

India

Facility Name

Novartis Investigative Site

City

Hyderabad

ZIP/Postal Code

500 063

Country

India

Facility Name

Novartis Investigative Site

City

Kolkota

ZIP/Postal Code

700020

Country

India

Facility Name

Novartis Investigative Site

City

New Delhi

ZIP/Postal Code

110 029

Country

India

Facility Name

Novartis Investigative Site

City

L'Aquila

State/Province

ZIP/Postal Code

67100

Country

Italy

Facility Name

Novartis Investigative Site

City

Bergamo

State/Province

ZIP/Postal Code

24128

Country

Italy

Facility Name

Novartis Investigative Site

City

Belluno

State/Province

ZIP/Postal Code

32100

Country

Italy

Facility Name

Novartis Investigative Site

City

Bologna

State/Province

ZIP/Postal Code

40138

Country

Italy

Facility Name

Novartis Investigative Site

City

Campobasso

State/Province

ZIP/Postal Code

86100

Country

Italy

Facility Name

Novartis Investigative Site

City

Caserta

State/Province

ZIP/Postal Code

81100

Country

Italy

Facility Name

Novartis Investigative Site

City

Chieti

State/Province

ZIP/Postal Code

66100

Country

Italy

Facility Name

Novartis Investigative Site

City

Cuneo

State/Province

ZIP/Postal Code

12100

Country

Italy

Facility Name

Novartis Investigative Site

City

Cosenza

State/Province

ZIP/Postal Code

87100

Country

Italy

Facility Name

Novartis Investigative Site

City

Catanzaro

State/Province

ZIP/Postal Code

88100

Country

Italy

Facility Name

Novartis Investigative Site

City

Cona

State/Province

ZIP/Postal Code

44100

Country

Italy

Facility Name

Novartis Investigative Site

City

Foggia

State/Province

ZIP/Postal Code

71100

Country

Italy

Facility Name

Novartis Investigative Site

City

Firenze

State/Province

ZIP/Postal Code

50134

Country

Italy

Facility Name

Novartis Investigative Site

City

Arenzano

State/Province

ZIP/Postal Code

16011

Country

Italy

Facility Name

Novartis Investigative Site

City

Genova

State/Province

ZIP/Postal Code

16132

Country

Italy

Facility Name

Novartis Investigative Site

City

Pozzilli

State/Province

ZIP/Postal Code

86077

Country

Italy

Facility Name

Novartis Investigative Site

City

Lecco

State/Province

ZIP/Postal Code

23900

Country

Italy

Facility Name

Novartis Investigative Site

City

Monza

State/Province

ZIP/Postal Code

20900

Country

Italy

Facility Name

Novartis Investigative Site

City

Milano

State/Province

ZIP/Postal Code

20123

Country

Italy

Facility Name

Novartis Investigative Site

City

Milano

State/Province

ZIP/Postal Code

20132

Country

Italy

Facility Name

Novartis Investigative Site

City

Milano

State/Province

ZIP/Postal Code

20146

Country

Italy

Facility Name

Novartis Investigative Site

City

Milano

State/Province

ZIP/Postal Code

20157

Country

Italy

Facility Name

Novartis Investigative Site

City

Passirana di Rho

State/Province

ZIP/Postal Code

20017

Country

Italy

Facility Name

Novartis Investigative Site

City

Palermo

State/Province

ZIP/Postal Code

90127

Country

Italy

Facility Name

Novartis Investigative Site

City

Perugia

State/Province

ZIP/Postal Code

06100

Country

Italy

Facility Name

Novartis Investigative Site

City

Pisa

State/Province

ZIP/Postal Code

56124

Country

Italy

Facility Name

Novartis Investigative Site

City

Pisa

State/Province

ZIP/Postal Code

56126

Country

Italy

Facility Name

Novartis Investigative Site

City

Pordenone

State/Province

ZIP/Postal Code

33170

Country

Italy

Facility Name

Novartis Investigative Site

City

Parma

State/Province

ZIP/Postal Code

43100

Country

Italy

Facility Name

Novartis Investigative Site

City

Casorate Primo

State/Province

ZIP/Postal Code

27022

Country

Italy

Facility Name

Novartis Investigative Site

City

Pavia

State/Province

ZIP/Postal Code

27100

Country

Italy

Facility Name

Novartis Investigative Site

City

Stradella

State/Province

ZIP/Postal Code

27049

Country

Italy

Facility Name

Novartis Investigative Site

City

Ravenna

State/Province

ZIP/Postal Code

48100

Country

Italy

Facility Name

Novartis Investigative Site

City

Roma

State/Province

ZIP/Postal Code

00122

Country

Italy

Facility Name

Novartis Investigative Site

City

Roma

State/Province

ZIP/Postal Code

00133

Country

Italy

Facility Name

Novartis Investigative Site

City

Roma

State/Province

ZIP/Postal Code

00157

Country

Italy

Facility Name

Novartis Investigative Site

City

Roma

State/Province

ZIP/Postal Code

00161

Country

Italy

Facility Name

Novartis Investigative Site

City

Roma

State/Province

ZIP/Postal Code

00163

Country

Italy

Facility Name

Novartis Investigative Site

City

Roma

State/Province

ZIP/Postal Code

00186

Country

Italy

Facility Name

Novartis Investigative Site

City

Roma

State/Province

ZIP/Postal Code

00189

Country

Italy

Facility Name

Novartis Investigative Site

City

Cava De' Tirreni

State/Province

ZIP/Postal Code

84013

Country

Italy

Facility Name

Novartis Investigative Site

City

Mercato San Severino

State/Province

ZIP/Postal Code

84085

Country

Italy

Facility Name

Novartis Investigative Site

City

Salerno

State/Province

ZIP/Postal Code

84125

Country

Italy

Facility Name

Novartis Investigative Site

City

Siena

State/Province

ZIP/Postal Code

53100

Country

Italy

Facility Name

Novartis Investigative Site

City

Olbia

State/Province

ZIP/Postal Code

07026

Country

Italy

Facility Name

Novartis Investigative Site

City

Sassari

State/Province

ZIP/Postal Code

07100

Country

Italy

Facility Name

Novartis Investigative Site

City

Torino

State/Province

ZIP/Postal Code

10126

Country

Italy

Facility Name

Novartis Investigative Site

City

Torino

State/Province

ZIP/Postal Code

10128

Country

Italy

Facility Name

Novartis Investigative Site

City

Torino

State/Province

ZIP/Postal Code

10154

Country

Italy

Facility Name

Novartis Investigative Site

City

Vittorio Veneto

State/Province

ZIP/Postal Code

31029

Country

Italy

Facility Name

Novartis Investigative Site

City

San Daniele Del Friuli

State/Province

ZIP/Postal Code

33038

Country

Italy

Facility Name

Novartis Investigative Site

City

Udine

State/Province

ZIP/Postal Code

33100

Country

Italy

Facility Name

Novartis Investigative Site

City

Venezia

State/Province

ZIP/Postal Code

30174

Country

Italy

Facility Name

Novartis Investigative Site

City

Verona

State/Province

ZIP/Postal Code

37126

Country

Italy

Facility Name

Novartis Investigative Site

City

Isernia

ZIP/Postal Code

86170

Country

Italy

Facility Name

Novartis Investigative Site

City

Napoli

ZIP/Postal Code

80131

Country

Italy

Facility Name

Novartis Investigative Site

City

Nagoya

State/Province

Aichi

ZIP/Postal Code

451-8511

Country

Japan

Facility Name

Novartis Investigative Site

City

Nagoya

State/Province

Aichi

ZIP/Postal Code

455-8530

Country

Japan

Facility Name

Novartis Investigative Site

City

Nagoya

State/Province

Aichi

ZIP/Postal Code

460-0001

Country

Japan

Facility Name

Novartis Investigative Site

City

Nagoya

State/Province

Aichi

ZIP/Postal Code

462-0802

Country

Japan

Facility Name

Novartis Investigative Site

City

Nagoya

State/Province

Aichi

ZIP/Postal Code

462-0825

Country

Japan

Facility Name

Novartis Investigative Site

City

Asahi

State/Province

Chiba

ZIP/Postal Code

289-2511

Country

Japan

Facility Name

Novartis Investigative Site

City

Kasuga

State/Province

Fukuoka

ZIP/Postal Code

816-0864

Country

Japan

Facility Name

Novartis Investigative Site

City

Kitakyushu

State/Province

Fukuoka

ZIP/Postal Code

800-0296

Country

Japan

Facility Name

Novartis Investigative Site

City

Koriyama-city

State/Province

Fukushima

ZIP/Postal Code

963-8851

Country

Japan

Facility Name

Novartis Investigative Site

City

Asahikawa

State/Province

Hokkaido

ZIP/Postal Code

078-8211

Country

Japan

Facility Name

Novartis Investigative Site

City

Sapporo-city

State/Province

Hokkaido

ZIP/Postal Code

060-8648

Country

Japan

Facility Name

Novartis Investigative Site

City

Sapporo

State/Province

Hokkaido

ZIP/Postal Code

003-0023

Country

Japan

Facility Name

Novartis Investigative Site

City

Sapporo

State/Province

Hokkaido

ZIP/Postal Code

060-0033

Country

Japan

Facility Name

Novartis Investigative Site

City

Toride-city

State/Province

Ibaraki

ZIP/Postal Code

302-0022

Country

Japan

Facility Name

Novartis Investigative Site

City

Takamatsu

State/Province

Kagawa

ZIP/Postal Code

7600076

Country

Japan

Facility Name

Novartis Investigative Site

City

Aira-city

State/Province

Kagoshima

ZIP/Postal Code

899-5431

Country

Japan

Facility Name

Novartis Investigative Site

City

Isehara-city

State/Province

Kanagawa

ZIP/Postal Code

259-1131

Country

Japan

Facility Name

Novartis Investigative Site

City

Kawasaki

State/Province

Kanagawa

ZIP/Postal Code

210-0852

Country

Japan

Facility Name

Novartis Investigative Site

City

Yatsushiro

State/Province

Kumamoto

ZIP/Postal Code

866-8660

Country

Japan

Facility Name

Novartis Investigative Site

City

Kyoto-city

State/Province

Kyoto

ZIP/Postal Code

612-8555

Country

Japan

Facility Name

Novartis Investigative Site

City

Kyoto-city

State/Province

Kyoto

ZIP/Postal Code

615-0035

Country

Japan

Facility Name

Novartis Investigative Site

City

Sendai-city

State/Province

Miyagi

ZIP/Postal Code

980-8574

Country

Japan

Facility Name

Novartis Investigative Site

City

Suwa

State/Province

Nagano

ZIP/Postal Code

392-8510

Country

Japan

Facility Name

Novartis Investigative Site

City

Okayama-city

State/Province

Okayama

ZIP/Postal Code

700-8558

Country

Japan

Facility Name

Novartis Investigative Site

City

Takatsuki-city

State/Province

Osaka

ZIP/Postal Code

569-1096

Country

Japan

Facility Name

Novartis Investigative Site

City

Toyonaka

State/Province

Osaka

ZIP/Postal Code

561-0871

Country

Japan

Facility Name

Novartis Investigative Site

City

Yao-city

State/Province

Osaka

ZIP/Postal Code

581-0011

Country

Japan

Facility Name

Novartis Investigative Site

City

Tokorozawa

State/Province

Saitama

ZIP/Postal Code

351-1151

Country

Japan

Facility Name

Novartis Investigative Site

City

Ohtsu-city

State/Province

Shiga

ZIP/Postal Code

520-2192

Country

Japan

Facility Name

Novartis Investigative Site

City

Shimizu

State/Province

Shizuoka

ZIP/Postal Code

411-8611

Country

Japan

Facility Name

Novartis Investigative Site

City

Bunkyo-ku

State/Province

Tokyo

ZIP/Postal Code

113-8655

Country

Japan

Facility Name

Novartis Investigative Site

City

Chuo-ku

State/Province

Tokyo

ZIP/Postal Code

103-0002

Country

Japan

Facility Name

Novartis Investigative Site

City

Takaoka

State/Province

Toyama

ZIP/Postal Code

933-0955

Country

Japan

Facility Name

Novartis Investigative Site

City

Oita

ZIP/Postal Code

870-0039

Country

Japan

Facility Name

Novartis Investigative Site

City

Oita

ZIP/Postal Code

870-0192

Country

Japan

Facility Name

Novartis Investigative Site

City

Okayama

ZIP/Postal Code

701-1192

Country

Japan

Facility Name

Novartis Investigative Site

City

Ansan

State/Province

Gyeonggi-do

ZIP/Postal Code

425-801

Country

Korea, Republic of

Facility Name

Novartis Investigative Site

City

Anyang

State/Province

Gyeonggi-do

ZIP/Postal Code

431-070

Country

Korea, Republic of

Facility Name

Novartis Investigative Site

City

Seoul

State/Province

Korea

ZIP/Postal Code

110 744

Country

Korea, Republic of

Facility Name

Novartis Investigative Site

City

Seoul

State/Province

Korea

ZIP/Postal Code

120-752

Country

Korea, Republic of

Facility Name

Novartis Investigative Site

City

Seoul

State/Province

Korea

ZIP/Postal Code

135-710

Country

Korea, Republic of

Facility Name

Novartis Investigative Site

City

Bundang

State/Province

Seongnam

ZIP/Postal Code

463-707

Country

Korea, Republic of

Facility Name

Novartis Investigative Site

City

Busan

ZIP/Postal Code

602-739

Country

Korea, Republic of

Facility Name

Novartis Investigative Site

City

Daejeon

ZIP/Postal Code

301-747

Country

Korea, Republic of

Facility Name

Novartis Investigative Site

City

Incheon

ZIP/Postal Code

400-712

Country

Korea, Republic of

Facility Name

Novartis Investigative Site

City

Pusan

ZIP/Postal Code

614-735

Country

Korea, Republic of

Facility Name

Novartis Investigative Site

City

Seoul

ZIP/Postal Code

135-720

Country

Korea, Republic of

Facility Name

Novartis Investigative Site

City

Seoul

ZIP/Postal Code

136 705

Country

Korea, Republic of

Facility Name

Novartis Investigative Site

City

Seoul

ZIP/Postal Code

137-701

Country

Korea, Republic of

Facility Name

Novartis Investigative Site

City

Seoul

ZIP/Postal Code

152-703

Country

Korea, Republic of

Facility Name

Novartis Investigative Site

City

Seoul

ZIP/Postal Code

156-707

Country

Korea, Republic of

Facility Name

Novartis Investigative Site

City

Taegu

ZIP/Postal Code

700 - 721

Country

Korea, Republic of

Facility Name

Novartis Investigative Site

City

Kaunas

ZIP/Postal Code

50009

Country

Lithuania

Facility Name

Novartis Investigative Site

City

Klaipeda

ZIP/Postal Code

92304

Country

Lithuania

Facility Name

Novartis Investigative Site

City

Vilnius

ZIP/Postal Code

LT-08661

Country

Lithuania

Facility Name

Novartis Investigative Site

City

Vilnius

Country

Lithuania

Facility Name

Novartis Investigative Site

City

Alkmaar

ZIP/Postal Code

1851 JD

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Almelo

ZIP/Postal Code

7609 PP

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Amersfoort

ZIP/Postal Code

3800 BM

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Amsterdam

ZIP/Postal Code

1061 AE

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Apeldoorn

ZIP/Postal Code

7334 DZ

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Arnhem

ZIP/Postal Code

6815 AD

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Breda

ZIP/Postal Code

4818 CK

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Delft

ZIP/Postal Code

2625 AD

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Den Helder

ZIP/Postal Code

1782 GZ

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Deventer

ZIP/Postal Code

7416 SE

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Doetinchem

ZIP/Postal Code

7009 BL

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Dordrecht

ZIP/Postal Code

3318AT

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Eindhoven

ZIP/Postal Code

5623 EJ

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Eindhoven

ZIP/Postal Code

5631 BM

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Goes

ZIP/Postal Code

4462 RA

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Groningen

ZIP/Postal Code

9713 GZ

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Heerlen

ZIP/Postal Code

6419 PC

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Hoogeveen

ZIP/Postal Code

7909 AA

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Hoogwoud

ZIP/Postal Code

1718 BG

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Losser

ZIP/Postal Code

7581 BV

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Meppel

ZIP/Postal Code

7943 KA

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Nieuwegein

ZIP/Postal Code

3435 CM

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Oude Pekela

ZIP/Postal Code

9665 AR

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Rotterdam

ZIP/Postal Code

3015 CE

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Rotterdam

ZIP/Postal Code

3045 PM

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Rotterdam

ZIP/Postal Code

3083 AN

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Tiel

ZIP/Postal Code

4002 WP

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Utrecht

ZIP/Postal Code

3508 GA

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Venlo

ZIP/Postal Code

5912 BL

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Woerden

ZIP/Postal Code

3443 GG

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Zwijndrecht

ZIP/Postal Code

NL-3331 LZ

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Zwolle

ZIP/Postal Code

8025 AB

Country

Netherlands

Facility Name

Novartis Investigative Site

City

Bergen

ZIP/Postal Code

5013

Country

Norway

Facility Name

Novartis Investigative Site

City

Fredrikstad

ZIP/Postal Code

1607

Country

Norway

Facility Name

Novartis Investigative Site

City

Horten

ZIP/Postal Code

3191

Country

Norway

Facility Name

Novartis Investigative Site

City

Hønefoss

ZIP/Postal Code

3515

Country

Norway

Facility Name

Novartis Investigative Site

City

Oslo

ZIP/Postal Code

0160

Country

Norway

Facility Name

Novartis Investigative Site

City

Skedsmokorset

ZIP/Postal Code

2020

Country

Norway

Facility Name

Novartis Investigative Site

City

Skien

ZIP/Postal Code

3722

Country

Norway

Facility Name

Novartis Investigative Site

City

Spikkestad

ZIP/Postal Code

3430

Country

Norway

Facility Name

Novartis Investigative Site

City

Stavanger

ZIP/Postal Code

4011

Country

Norway

Facility Name

Novartis Investigative Site

City

Svelvik

ZIP/Postal Code

3060

Country

Norway

Facility Name

Novartis Investigative Site

City

Tromsø

ZIP/Postal Code

NO-9038

Country

Norway

Facility Name

Novartis Investigative Site

City

Trondheim

ZIP/Postal Code

NO-7011

Country

Norway

Facility Name

Novartis Investigative Site

City

Tønsberg

ZIP/Postal Code

3103

Country

Norway

Facility Name

Novartis Investigative Site

City

Bellavista

State/Province

Lima

ZIP/Postal Code

Callao 02

Country

Peru

Facility Name

Novartis Investigative Site

City

Cercado de Lima

State/Province

Lima

ZIP/Postal Code

Country

Peru

Facility Name

Novartis Investigative Site

City

San Borja

State/Province

Lima

ZIP/Postal Code

Country

Peru

Facility Name

Novartis Investigative Site

City

San Isidro

State/Province

Lima

ZIP/Postal Code

Country

Peru

Facility Name

Novartis Investigative Site

City

San Martin de Porres

State/Province

Lima

ZIP/Postal Code

Country

Peru

Facility Name

Novartis Investigative Site

City

Santiago de Surco

State/Province

Lima

ZIP/Postal Code

Country

Peru

Facility Name

Novartis Investigative Site

City

Almada

ZIP/Postal Code

2801-951

Country

Portugal

Facility Name

Novartis Investigative Site

City

Amadora

ZIP/Postal Code

2720-276

Country

Portugal

Facility Name

Novartis Investigative Site

City

Coimbra

ZIP/Postal Code

3000-075

Country

Portugal

Facility Name

Novartis Investigative Site

City

Linda-a-Velha

ZIP/Postal Code

2799-523

Country

Portugal

Facility Name

Novartis Investigative Site

City

Lisboa

ZIP/Postal Code

1169-024

Country

Portugal

Facility Name

Novartis Investigative Site

City

Lisboa

ZIP/Postal Code

1250-203

Country

Portugal

Facility Name

Novartis Investigative Site

City

Lisboa

ZIP/Postal Code

1495-005

Country

Portugal

Facility Name

Novartis Investigative Site

City

Lisboa

ZIP/Postal Code

1649-035

Country

Portugal

Facility Name

Novartis Investigative Site

City

Matosinhos

ZIP/Postal Code

4454-509

Country

Portugal

Facility Name

Novartis Investigative Site

City

Portimão

ZIP/Postal Code

8500-388

Country

Portugal

Facility Name

Novartis Investigative Site

City

Porto

ZIP/Postal Code

4200-319

Country

Portugal

Facility Name

Novartis Investigative Site

City

Santa Maria da Feira

ZIP/Postal Code

4520-211

Country

Portugal

Facility Name

Novartis Investigative Site

City

Santarém

ZIP/Postal Code

2000-153

Country

Portugal

Facility Name

Novartis Investigative Site

City

Ponce

ZIP/Postal Code

00716

Country

Puerto Rico

Facility Name

Novartis Investigative Site

City

Ponce

ZIP/Postal Code

00733-1471

Country

Puerto Rico

Facility Name

Novartis Investigative Site

City

Singapore

ZIP/Postal Code

119074

Country

Singapore

Facility Name

Novartis Investigative Site

City

Singapore

ZIP/Postal Code

159964

Country

Singapore

Facility Name

Novartis Investigative Site

City

Singapore

ZIP/Postal Code

168752

Country

Singapore

Facility Name

Novartis Investigative Site

City

Singapore

ZIP/Postal Code

169608

Country

Singapore

Facility Name

Novartis Investigative Site

City

Singapore

ZIP/Postal Code

308433

Country

Singapore

Facility Name

Novartis Investigative Site

City

Bratislava

State/Province

Slovak Republic

ZIP/Postal Code

826 06

Country

Slovakia

Facility Name

Novartis Investigative Site

City

Kosice

State/Province

Slovak Republic

ZIP/Postal Code

040 22

Country

Slovakia

Facility Name

Novartis Investigative Site

City

Zilina

State/Province

Slovak Republic

ZIP/Postal Code

010 01

Country

Slovakia

Facility Name

Novartis Investigative Site

City

Banksa Bystrica

ZIP/Postal Code

SK 97 517

Country

Slovakia

Facility Name

Novartis Investigative Site

City

Bratislava

ZIP/Postal Code

811 08

Country

Slovakia

Facility Name

Novartis Investigative Site

City

Bratislava

ZIP/Postal Code

812 72

Country

Slovakia

Facility Name

Novartis Investigative Site

City

Bratislava

ZIP/Postal Code

81369

Country

Slovakia

Facility Name

Novartis Investigative Site

City

Bratislava

ZIP/Postal Code

833 48

Country

Slovakia

Facility Name

Novartis Investigative Site

City

Bratislava

ZIP/Postal Code

851 07

Country

Slovakia

Facility Name

Novartis Investigative Site

City

Kosice

ZIP/Postal Code

040 01

Country

Slovakia

Facility Name

Novartis Investigative Site

City

Lubochna

ZIP/Postal Code

SK 03491

Country

Slovakia

Facility Name

Novartis Investigative Site

City

Lucenec

ZIP/Postal Code

98439

Country

Slovakia

Facility Name

Novartis Investigative Site

City

Martin

ZIP/Postal Code

03601

Country

Slovakia

Facility Name

Novartis Investigative Site

City

Nitra

ZIP/Postal Code

949 01

Country

Slovakia

Facility Name

Novartis Investigative Site

City

Piestany

ZIP/Postal Code

921 01

Country

Slovakia

Facility Name

Novartis Investigative Site

City

Prievidza

ZIP/Postal Code

971 01

Country

Slovakia

Facility Name

Novartis Investigative Site

City

Trstena

ZIP/Postal Code

549 16

Country

Slovakia

Facility Name

Novartis Investigative Site

City

Somerset West

State/Province

Western Cape

ZIP/Postal Code

7130

Country

South Africa

Facility Name

Novartis Investigative Site

City

Cape Town

ZIP/Postal Code

7925

Country

South Africa

Facility Name

Novartis Investigative Site

City

Durban

ZIP/Postal Code

4001

Country

South Africa

Facility Name

Novartis Investigative Site

City

Durban

ZIP/Postal Code

4030

Country

South Africa

Facility Name

Novartis Investigative Site

City

Durban

ZIP/Postal Code

4052

Country

South Africa

Facility Name

Novartis Investigative Site

City

Durban

ZIP/Postal Code

4110

Country

South Africa

Facility Name

Novartis Investigative Site

City

Gauteng

Country

South Africa

Facility Name

Novartis Investigative Site

City

Johannesburg

ZIP/Postal Code

2196

Country

South Africa

Facility Name

Novartis Investigative Site

City

Port Elizabeth

ZIP/Postal Code

6001

Country

South Africa

Facility Name

Novartis Investigative Site

City

Pretoria

ZIP/Postal Code

0002

Country

South Africa

Facility Name

Novartis Investigative Site

City

Cadiz

State/Province

Andalucia

ZIP/Postal Code

11010

Country

Spain

Facility Name

Novartis Investigative Site

City

Granada

State/Province

Andalucia

ZIP/Postal Code

18014

Country

Spain

Facility Name

Novartis Investigative Site

City

Jerez de La Frontera

State/Province

Andalucia

ZIP/Postal Code

11407

Country

Spain

Facility Name

Novartis Investigative Site

City

Malaga

State/Province

Andalucia

ZIP/Postal Code

29010

Country

Spain

Facility Name

Novartis Investigative Site

City

Malaga

State/Province

Andalucia

ZIP/Postal Code

29018

Country

Spain

Facility Name

Novartis Investigative Site

City

Málaga

State/Province

Andalucia

ZIP/Postal Code

29010

Country

Spain

Facility Name

Novartis Investigative Site

City

Puerto de Santa Maria

State/Province

Andalucia

ZIP/Postal Code

11500

Country

Spain

Facility Name

Novartis Investigative Site

City

Sanlúcar de Barrameda

State/Province

Andalucia

ZIP/Postal Code

11540

Country

Spain

Facility Name

Novartis Investigative Site

City

Sevilla

State/Province

Andalucia

ZIP/Postal Code

41009

Country

Spain

Facility Name

Novartis Investigative Site

City

Oviedo

State/Province

Asturias

ZIP/Postal Code

33006

Country

Spain

Facility Name

Novartis Investigative Site

City

Oviedo

State/Province

Asturias

ZIP/Postal Code

33008

Country

Spain

Facility Name

Novartis Investigative Site

City

Oviedo

State/Province

Asturias

ZIP/Postal Code

33010

Country

Spain

Facility Name

Novartis Investigative Site

City

Hospitalet de Llobregat

State/Province

Barcelona

ZIP/Postal Code

08907

Country

Spain

Facility Name

Novartis Investigative Site

City

Sabadell

State/Province

Barcelona

ZIP/Postal Code

08208

Country

Spain

Facility Name

Novartis Investigative Site

City

Alcazar de San Juan

State/Province

Castilla la Mancha

ZIP/Postal Code

13600

Country

Spain

Facility Name

Novartis Investigative Site

City

Aranda de Duero

State/Province

Castilla y Leon

ZIP/Postal Code

09400

Country

Spain

Facility Name

Novartis Investigative Site

City

Miranda de Ebro

State/Province

Castilla y Leon

ZIP/Postal Code

09200

Country

Spain

Facility Name

Novartis Investigative Site

City

Barcelona

State/Province

Catalunya

ZIP/Postal Code

08025

Country

Spain

Facility Name

Novartis Investigative Site

City

Barcelona

State/Province

Cataluña

ZIP/Postal Code

08025

Country

Spain

Facility Name

Novartis Investigative Site

City

Barcelona

State/Province

Cataluña

ZIP/Postal Code

08905

Country

Spain

Facility Name

Novartis Investigative Site

City

Girona

State/Province

Cataluña

ZIP/Postal Code

17007

Country

Spain

Facility Name

Novartis Investigative Site

City

La Pobla Llarga

State/Province

Cataluña

ZIP/Postal Code

46670

Country

Spain

Facility Name

Novartis Investigative Site

City

Llança

State/Province

Cataluña

ZIP/Postal Code

17490

Country

Spain

Facility Name

Novartis Investigative Site

City

Manresa

State/Province

Cataluña

ZIP/Postal Code

08240

Country

Spain

Facility Name

Novartis Investigative Site

City

Mollet del Vallés

State/Province

Cataluña

ZIP/Postal Code

08100

Country

Spain

Facility Name

Novartis Investigative Site

City

Rubi

State/Province

Cataluña

ZIP/Postal Code

08191

Country

Spain

Facility Name

Novartis Investigative Site

City

Santa Coloma de Gramanet

State/Province

Cataluña

ZIP/Postal Code

08923

Country

Spain

Facility Name

Novartis Investigative Site

City

Tarrega

State/Province

Cataluña

ZIP/Postal Code

25300

Country

Spain

Facility Name

Novartis Investigative Site

City

Vic

State/Province

Cataluña

ZIP/Postal Code

08500

Country

Spain

Facility Name

Novartis Investigative Site

City

Alacuas

State/Province

Comunidad Valenciana

ZIP/Postal Code

46970

Country

Spain

Facility Name

Novartis Investigative Site

City

Alicante

State/Province

Comunidad Valenciana

ZIP/Postal Code

03004

Country

Spain

Facility Name

Novartis Investigative Site

City

Alzira

State/Province

Comunidad Valenciana

ZIP/Postal Code

46600

Country

Spain

Facility Name

Novartis Investigative Site

City

Benidorm

State/Province

Comunidad Valenciana

ZIP/Postal Code

03550

Country

Spain

Facility Name

Novartis Investigative Site

City

Puerto de Sagunto

State/Province

Comunidad Valenciana

ZIP/Postal Code

46520

Country

Spain

Facility Name

Novartis Investigative Site

City

Quart de Poblet

State/Province

Comunidad Valenciana

ZIP/Postal Code

46930

Country

Spain

Facility Name

Novartis Investigative Site

City

Valencia

State/Province

Comunidad Valenciana

ZIP/Postal Code

46010

Country

Spain

Facility Name

Novartis Investigative Site

City

Valencia

State/Province

Comunidad Valenciana

ZIP/Postal Code

46011

Country

Spain

Facility Name

Novartis Investigative Site

City

Valencia

State/Province

Comunidad Valenciana

ZIP/Postal Code

46014

Country

Spain

Facility Name

Novartis Investigative Site

City

Valencia

State/Province

Comunidad Valenciana

ZIP/Postal Code

46017

Country

Spain

Facility Name

Novartis Investigative Site

City

Valencia

State/Province

Comunidad Valenciana

ZIP/Postal Code

46019

Country

Spain

Facility Name

Novartis Investigative Site

City

Xixona

State/Province

Comunidad Valenciana

ZIP/Postal Code

03100

Country

Spain

Facility Name

Novartis Investigative Site

City

Mérida

State/Province

Extremadura

ZIP/Postal Code

06800

Country

Spain

Facility Name

Novartis Investigative Site

City

Begonte

State/Province

Galicia

ZIP/Postal Code

27373

Country

Spain

Facility Name

Novartis Investigative Site

City

Ferrol

State/Province

Galicia

ZIP/Postal Code

15405

Country

Spain

Facility Name

Novartis Investigative Site

City

La Coruña

State/Province

Galicia

ZIP/Postal Code

15010

Country

Spain

Facility Name

Novartis Investigative Site

City

Pontevedra

State/Province

Galicia

ZIP/Postal Code

36071

Country

Spain

Facility Name

Novartis Investigative Site

City

Santiago de Compostela

State/Province

Galicia

ZIP/Postal Code

15706

Country

Spain

Facility Name

Novartis Investigative Site

City

Vigo

State/Province

Galicia

ZIP/Postal Code

36200

Country

Spain

Facility Name

Novartis Investigative Site

City

Palma De Mallorca

State/Province

Islas Baleares

Country

Spain

Facility Name

Novartis Investigative Site

City

Alcorcón

State/Province

Madrid

ZIP/Postal Code

28922

Country

Spain

Facility Name

Novartis Investigative Site

City

Arganda del Rey

State/Province

Madrid

ZIP/Postal Code

28500

Country

Spain

Facility Name

Novartis Investigative Site

City

Civdad Real

State/Province

Madrid

ZIP/Postal Code

13002

Country

Spain

Facility Name

Novartis Investigative Site

City

Murcia

State/Province

Madrid

ZIP/Postal Code

30007

Country

Spain

Facility Name

Novartis Investigative Site

City

Plentzia

State/Province

Pais Vasco

ZIP/Postal Code

48620

Country

Spain

Facility Name

Novartis Investigative Site

City

San Sebastian

State/Province

Pais Vasco

ZIP/Postal Code

20014

Country

Spain

Facility Name

Novartis Investigative Site

City

Villabona

State/Province

Pais Vasco

ZIP/Postal Code

20150

Country

Spain

Facility Name

Novartis Investigative Site

City

Zumarraga

State/Province

Pais Vasco

ZIP/Postal Code

20700

Country

Spain

Facility Name

Novartis Investigative Site

City

Alfaro

State/Province

Rioja

ZIP/Postal Code

26540

Country

Spain

Facility Name

Novartis Investigative Site

City

Logroño

State/Province

Rioja

ZIP/Postal Code

26005

Country

Spain

Facility Name

Novartis Investigative Site

City

Hospitalet de Llbregat

ZIP/Postal Code

08902

Country

Spain

Facility Name

Novartis Investigative Site

City

Hospitalet de Llobregat

Country

Spain

Facility Name

Novartis Investigative Site

City

Madrid

ZIP/Postal Code

28034

Country

Spain

Facility Name

Novartis Investigative Site

City

Madrid

ZIP/Postal Code

28035

Country

Spain

Facility Name

Novartis Investigative Site

City

Madrid

ZIP/Postal Code

28040

Country

Spain

Facility Name

Novartis Investigative Site

City

Madrid

ZIP/Postal Code

28041

Country

Spain

Facility Name

Novartis Investigative Site

City

Madrid

ZIP/Postal Code

28046

Country

Spain

Facility Name

Novartis Investigative Site

City

Madrid

ZIP/Postal Code

28770

Country

Spain

Facility Name

Novartis Investigative Site

City

Göteborg

ZIP/Postal Code

SE-412 55

Country

Sweden

Facility Name

Novartis Investigative Site

City

Helsingborg

ZIP/Postal Code

251 87

Country

Sweden

Facility Name

Novartis Investigative Site

City

Karlstad

ZIP/Postal Code

651 85

Country

Sweden

Facility Name

Novartis Investigative Site

City

Malmö

ZIP/Postal Code

21152

Country

Sweden

Facility Name

Novartis Investigative Site

City

Rättvik

ZIP/Postal Code

79530

Country

Sweden

Facility Name

Novartis Investigative Site

City

Stenstorp

ZIP/Postal Code

SE-521 60

Country

Sweden

Facility Name

Novartis Investigative Site

City

Uppsala

ZIP/Postal Code

751 85

Country

Sweden

Facility Name

Novartis Investigative Site

City

Varberg

ZIP/Postal Code

s-432 81

Country

Sweden

Facility Name

Novartis Investigative Site

City

Estavayer-le-Lac

State/Province

ZIP/Postal Code

1470

Country

Switzerland

Facility Name

Novartis Investigative Site

City

Ascona

Country

Switzerland

Facility Name

Novartis Investigative Site

City

Bern

ZIP/Postal Code

3010

Country

Switzerland

Facility Name

Novartis Investigative Site

City

Bolligen

ZIP/Postal Code

3065

Country

Switzerland

Facility Name

Novartis Investigative Site

City

Bruderholz

ZIP/Postal Code

4101

Country

Switzerland

Facility Name

Novartis Investigative Site

City

Fribourg

ZIP/Postal Code

1700

Country

Switzerland

Facility Name

Novartis Investigative Site

City

La Chaux-de-Fonds

ZIP/Postal Code

2300

Country

Switzerland

Facility Name

Novartis Investigative Site

City

Lausanne

ZIP/Postal Code

1011

Country

Switzerland

Facility Name

Novartis Investigative Site

City

Lugano

ZIP/Postal Code

6900

Country

Switzerland

Facility Name

Novartis Investigative Site

City

Lugano

ZIP/Postal Code

6903

Country

Switzerland

Facility Name

Novartis Investigative Site

City

Renens

ZIP/Postal Code

1020

Country

Switzerland

Facility Name

Novartis Investigative Site

City

Schaffhausen

ZIP/Postal Code

8200

Country

Switzerland

Facility Name

Novartis Investigative Site

City

St. Gallen

ZIP/Postal Code

9007

Country

Switzerland

Facility Name

Novartis Investigative Site

City

Winterthur

ZIP/Postal Code

8400

Country

Switzerland

Facility Name

Novartis Investigative Site

City

Zuerich

ZIP/Postal Code

8091

Country

Switzerland

Facility Name

Novartis Investigative Site

City

Yungkang

State/Province

Tainan

ZIP/Postal Code

710

Country

Taiwan

Facility Name

Novartis Investigative Site

City

Changhua

ZIP/Postal Code

500

Country

Taiwan

Facility Name

Novartis Investigative Site

City

Kaohsiung

ZIP/Postal Code

807

Country

Taiwan

Facility Name

Novartis Investigative Site

City

Niaosong Township

ZIP/Postal Code

83301

Country

Taiwan

Facility Name

Novartis Investigative Site

City

Taichung County

Country

Taiwan

Facility Name

Novartis Investigative Site

City

Taichung

ZIP/Postal Code

40705

Country

Taiwan

Facility Name

Novartis Investigative Site

City

Taichung

Country

Taiwan

Facility Name

Novartis Investigative Site

City

Taipei

ZIP/Postal Code

10002

Country

Taiwan

Facility Name

Novartis Investigative Site

City

Taipei

ZIP/Postal Code

114

Country

Taiwan

Facility Name

Novartis Investigative Site

City

Taipei

Country

Taiwan

Facility Name

Novartis Investigative Site

City

Bangkok

ZIP/Postal Code

10330

Country

Thailand

Facility Name

Novartis Investigative Site

City

Bangkok

ZIP/Postal Code

10400

Country

Thailand

Facility Name

Novartis Investigative Site

City

Bangkok

ZIP/Postal Code

10700

Country

Thailand

Facility Name

Novartis Investigative Site

City

Chiang Mai

ZIP/Postal Code

50200

Country

Thailand

Facility Name

Novartis Investigative Site

City

Altunizade

ZIP/Postal Code

34662

Country

Turkey

Facility Name

Novartis Investigative Site

City

Ankara

ZIP/Postal Code

06100

Country

Turkey

Facility Name

Novartis Investigative Site

City

Ankara

ZIP/Postal Code

06590

Country

Turkey

Facility Name

Novartis Investigative Site

City

Gaziantep

ZIP/Postal Code

27070

Country

Turkey

Facility Name

Novartis Investigative Site

City

Izmir

ZIP/Postal Code

35040

Country

Turkey

Facility Name

Novartis Investigative Site

City

Izmir

ZIP/Postal Code

35340

Country

Turkey

Facility Name

Novartis Investigative Site

City

Kocaeli

ZIP/Postal Code

41380

Country

Turkey

Facility Name

Novartis Investigative Site

City

High Wycombe

State/Province

Buckinghamshire

ZIP/Postal Code

HP11 2TT

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Truro

State/Province

Cornwall

ZIP/Postal Code

TR1 3LJ

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Paignton

State/Province

Devon

ZIP/Postal Code

TQ4 5LA

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Cornwall

State/Province

England

ZIP/Postal Code

PL23 1DT

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Welwyn Garden City,

State/Province

Hertfordshire

ZIP/Postal Code

AL7 4HQ

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Gravesend

State/Province

Kent

ZIP/Postal Code

DA1 24JW

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Glasgow

State/Province

Scotland

ZIP/Postal Code

G12 8TA

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

East Horsley

State/Province

Surrey

ZIP/Postal Code

KT24 6QT

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Crawley

State/Province

West Sussex

ZIP/Postal Code

RH10 7DX

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Bath

ZIP/Postal Code

BA2 3HT

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Cardiff

ZIP/Postal Code

CF14 4XN

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Cardiff

ZIP/Postal Code

CF5 4AD

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Glasgow

ZIP/Postal Code

G11 6NT

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Glasgow

ZIP/Postal Code

G21 3UW

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Irvine

ZIP/Postal Code

KA12 0AY

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Lancashire

ZIP/Postal Code

FY3 7EN

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Lancashire

ZIP/Postal Code

FY4 3AD

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

London

ZIP/Postal Code

NW10 7NS

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

London

ZIP/Postal Code

SE1 9RT

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

London

ZIP/Postal Code

SW17 0QT

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Manchester

ZIP/Postal Code

M13 9NT

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Merseyside

ZIP/Postal Code

L7 8PX

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Rugby

ZIP/Postal Code

CV21 5 PX

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Vale of Glanmorgan

ZIP/Postal Code

CF63 4AR

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Wrexham

ZIP/Postal Code

LL13 7TD

Country

United Kingdom

Facility Name

Novartis Investigative Site

City

Caracas

State/Province

Distrito Capital

ZIP/Postal Code

1010

Country

Venezuela

Facility Name

Novartis Investigative Site

City

Caracas

State/Province

Distrito Capital

ZIP/Postal Code

1020

Country

Venezuela

Facility Name

Novartis Investigative Site

City

Caracas

State/Province

Distrito Capital

ZIP/Postal Code

1040

Country

Venezuela

Facility Name

Novartis Investigative Site

City

Caracas

State/Province

Distrito Capital

ZIP/Postal Code

1080-A

Country

Venezuela

Facility Name

Novartis Investigative Site

City

Caracas

State/Province

Distrito Capital

ZIP/Postal Code

1100

Country

Venezuela

Facility Name

Novartis Investigative Site

City

Puerto Ordaz

State/Province

Estado Bolívar

ZIP/Postal Code

8050

Country

Venezuela

Facility Name

Novartis Investigative Site

City

Valencia

State/Province

Estado Carabobo

ZIP/Postal Code

2001

Country

Venezuela

Facility Name

Novartis Investigative Site

City

Caracas

State/Province

Estado Miranda

ZIP/Postal Code

1060

Country

Venezuela

12. IPD Sharing Statement

Citations:

PubMed Identifier

32964800

Citation

Malachias MVB, Jhund PS, Claggett BL, Wijkman MO, Bentley-Lewis R, Chaturvedi N, Desai AS, Haffner SM, Parving HH, Prescott MF, Solomon SD, De Zeeuw D, McMurray JJV, Pfeffer MA. NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus. J Am Heart Assoc. 2020 Oct 20;9(19):e017462. doi: 10.1161/JAHA.120.017462. Epub 2020 Sep 23.

Results Reference

derived

PubMed Identifier

26774608

Citation

Heerspink HJ, Persson F, Brenner BM, Chaturvedi N, Brunel P, McMurray JJ, Desai AS, Solomon SD, Pfeffer MA, Parving HH, de Zeeuw D. Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial. Lancet Diabetes Endocrinol. 2016 Apr;4(4):309-17. doi: 10.1016/S2213-8587(15)00469-6. Epub 2016 Jan 14.

Results Reference

derived

PubMed Identifier

23121378

Citation

Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Desai AS, Nicolaides M, Richard A, Xiang Z, Brunel P, Pfeffer MA; ALTITUDE Investigators. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med. 2012 Dec 6;367(23):2204-13. doi: 10.1056/NEJMoa1208799. Epub 2012 Nov 3.

Results Reference

derived

PubMed Identifier

19727007

Citation

Lambers Heerspink HJ, Perkovic V, de Zeeuw D. Renal and cardio-protective effects of direct renin inhibition: a systematic literature review. J Hypertens. 2009 Dec;27(12):2321-31. doi: 10.1097/HJH.0b013e3283310f92.

Results Reference

derived

Learn more about this trial

Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)

We'll reach out to this number within 24 hrs

Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) (ALTITUDE)

Type 2 Diabetes Mellitus, Cardiovascular Disease

About this trial

Eligibility Criteria

Sites / Locations

Arms of the Study

Arm 1

Arm 2

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

1. Study Identification

2. Study Status

3. Sponsor/Collaborators

4. Oversight

5. Study Description

6. Conditions and Keywords

7. Study Design

8. Arms, Groups, and Interventions

10. Eligibility

12. IPD Sharing Statement

Learn more about this trial